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ABSTRACT 
CEP290 AND THE PRIMARY CILIUM- UNDERSTANDING THE PROTEIN’S 
ROLE IN CILIARY HEALTH AND DISEASE 
Adam P. Wojno 
Jean Bennett M.D., Ph.D. 
 
Mutations in CEP290 are associated with phenotypes ranging from early 
onset retinal degeneration to embryonic lethal, multisystem disease. The 
association of CEP290 with disease in multiple tissues is believed to be due to its 
role in stabilizing the primary cilium, an organelle found on almost every cell in 
the body whose involvement in human health and disease has only recently been 
identified. Like many ciliary proteins, CEP290’s exact function in this structure 
and how mutations affecting the protein lead to disease remains relatively 
unclear. Here, a proposed mechanism of CEP290-associated disease 
pathogenesis is explored, finding severity of CEP290-associated disease 
correlates with the amount of functional CEP290 protein predicted to result from 
a given patient’s genotype. In addition, a potential interaction between CEP290 
and TTBK2, a kinase recently discovered to traffic to the base or the primary 
cilium before the onset of ciliogenesis, was observed, providing insight into a role 
of CEP290 in the early stages of cilium formation. 
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PREFACE 
 
I first became interested in Centrosomal Protein 290 kDa (CEP290) 
through its association with Leber Congenital Amaurosis (LCA), an inherited, 
retinal degenerative disease that results in abnormal vision first manifesting in 
infancy. Whatever (poor) vision is present then disappears over time as the 
retinal photoreceptors degenerate. The initial focus of the Bennett lab was on a 
form of LCA that is relatively rare – caused by mutations in the RPE65 gene. 
Mutations in the Centrosomal Protein 290 kDa (CEP290)-encoding gene are 
more common than those in the RPE65 gene, and are associated with over 20% 
of all cases of LCA. In addition to retinal degeneration, mutations in CEP290 are 
also associated with a spectrum of more severe disease states, including Senior-
Loken syndrome, Joubert Syndrome, and Meckel Gruber syndrome. This 
spectrum of diseases, including LCA, is responsible for phenotypes ranging from 
early onset retinal degeneration to embryonic lethal, systemic disease and is 
attributed to the role that CEP290 plays in stabilizing the primary cilium in 
multiple different cell types, including photoreceptors. 
 Primary cilia are found on nearly every mammalian cell where they 
function as sensory organelles, taking part in the first stages of signaling 
cascades such as those involving Hedgehog and Wnt. In addition, the organelle 
that connects the cellular body of a photoreceptor with the light sensing outer 
segment is known to be a modified primary cilium.  
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 While the Bennett laboratory has had success using adeno-associated 
virus (AAV) vectors in a gene augmentation approach for LCA due to mutations 
in the gene encoding RPE65, the CEP290 cDNA is roughly twice the size of the 
AAV cargo capacity. Thus, those afflicted with CEP290-associated disease are 
currently not candidates for an analogous gene augmentation therapy 
intervention. In addition, outside of its association with multiple disease states, 
relatively little is known about CEP290’s function in cilia and photoreceptors. The 
goal of this work has been to address this void with an emphasis on the 
relationship of CEP290 mutations and disease as well as the protein’s role in the 
development and maintenance of the primary cilium and/or photoreceptor. 
 In Chapter 1 of this discussion, I will briefly cover the history of the primary 
cilium with a focus on key findings that have brought the organelle to the 
attention of scientists from multiple fields. Chapter 2 will incorporate some of 
what we know about the role of cilia in the body with our understanding of 
CEP290 in an attempt to generate a model for CEP290-asociated disease 
pathogenesis.  In Chapter 3, I will take a step back to look more closely at the 
role of CEP290 in ciliary health and maintenance. Specifically, I will begin to 
investigate the potential role that CEP290 might play in the initiation of 
ciliogenesis and, in addition, comment on our current understanding of this 
process as well as contemplate the potential role of other proteins in cilium 
formation. Finally, in Chapter 4, I will discuss some remaining questions related 
to the work presented here and the potential future directions to address these.   
	  1	  
CHAPTER 1: The primary cilium- from vestigial to valuable 
The primary cilium, an organelle found on the surface of almost every cell 
type in the body (Singla and Reiter, 2006), has attracted an impressive surge of 
scientific interest since the beginning of the century. This non-motile structure, 
argued to be vestigial since it was first observed on human cells over a hundred 
years ago (Romero et al., 2011), is now known to be linked to multiple signaling 
pathways and diverse cellular functions. Mutations in genes newly discovered to 
be expressing ciliary protein products are continually being linked to previously 
unexplained diseases.  How the primary cilium has emerged as a key cellular 
player after so many years can be explained in part by technological advances, 
but also, and perhaps more readily, by the continued pursuit of a small 
community of scientists that maintained interest in an overlooked organelle. A 
commentary on this pursuit, highlighting crucial observations and the scientists 
involved will be discussed below. 
Cilia, flagella, and primary cilium 
To begin a discussion on the primary cilium, a few clarifying points should 
be made. Cilia, flagella, and primary cilia are all composed of three regions, the 
basal body, the transition zone, and the axoneme (Avasthi and Marshall, 2012; 
Seeley and Nachury, 2010). A pair of centrioles docked at the cellular membrane 
is the foundation of the basal body. From the basal body, a microtubule shaft is 
extended from the end of the mother centriole, producing the axoneme of the 
structure. The area at the base of the microtubule axoneme, most proximal to the 
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mother centriole is defined as the transition zone (Kobayashi and Dynlacht, 
2011). (Fig. 1, Top Panel)	   With a few exceptions, the axoneme of motile cilia and 
flagella, responsible for cellular 
locomotion or fluid movement in 
the case of a stationary cell, are 
composed of a 9+2 arrangement 
of microtubules while the non-
motile primary cilia are 
composed of a 9+0 arrangement 
(Fig. 1, Lower Panel) 
(Bloodgood, 2009). Outside of 
this difference, the main 
structural and mechanical 
characteristics of these ciliary 
organelles are very similar and, 
as such, related observations 
made in motile cilia or flagella, 
which tend to be much larger, 
are often conveyed to the 
smaller non-motile type. While 
the following discussion will 
Figure 1: The primary cilium. Top Panel- Cilia, 
flagella, and primary cilia are all composed of a 
basal body, transition zone, and axoneme. The 
ciliary membrane separates the axoneme from 
the extracellular space. Bottom Panel- A 9+0 
arrangement of microtubules is depicted on the 
left and a 9+2 arrangement is depicted on the 
right. *Figure 1, Top Panel adapted from 
Kobayashi and Dynlacht, 2011 
	  3	  
mainly center on the emergence of the non-motile cilia as an organelle of utmost 
importance, the history of cilia in general starts with motile cilia and flagella, 
described by many as the first observed cellular organelle (Bloodgood, 2009). 
Antony van Leeuwenhoek- “Little feet” 
 Born in Delft, Holland in 1632, Antony van Leeuwenhoek came from an 
unlikely start to become the first person to identify and describe protozoa and 
bacteria just years after Robert Hooke described the first example of a 
microorganism, the microfungus Mucor (Gest, 2004; Dobell, 1932). The son of a 
basket maker and a brewer’s daughter, Antony moved to Amsterdam at the age 
of 16 to work in a Linen-draper’s shop. After around seven years, working the 
previous few years as the shop’s bookkeeper, he returned to Delft, married, and 
opened a draper’s shop of his own.  
With no formal scientific training but armed with what he described as, “a 
craving after knowledge,” (Waggoner, 1996) Antony began making microscopes 
in his free time, observing up close a variety of subjects, from mold to bees. 
Resisting to publish anything himself, in part due to the fact that he only spoke 
and wrote in Dutch (Dobell, 1932), all of Leeuwenhoek’s work is described in 
letters that he sent to others. Many of these letters were addressed to Henry 
Oldenburg who held the post of the first Secretary of the Royal Society of 
London, a society based on the “promotion of natural knowledge” (Dobell, 1932). 
Oldenburg then translated and sent out Leeuwenhoek’s work to interested 
parties. In a letter to Oldenburg in 1674, Antony describes his findings made in a 
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sample of water taken from a pond that he noticed became a cloudy green color 
in the summer after being clear all winter. In this sample, Antony described 
several “earthy particles, and some green streaks, spirally wound serpent-wise.” 
(Dobell, 1932) In addition he mentioned the quick motion with which these 
particles moved and that they were no thicker than a strand of hair.  
A year later, in his 18th and probably most famous letter to the Royal 
Society, Leeuwenhoek further describes these particles. It is in this letter in which 
flagella and cilia are mentioned for the first time, describing the flagella in terms 
of the “motion, of stretching out and pulling together the tail,” and cilia as, 
“incredibly thin little feet, or little legs” (Dobell, 1932). Leeuwenhoek goes on to 
describe finding these creatures in various types of water under an assortment of 
conditions, helping to enlighten the world of a new, fascinating universe inhabited 
by microorganisms. 
The central flagellum 
 Around 200 years after Leeuwenhoek’s discovery, improved microscopes 
and the development of a new stain, iron-hematoxylin, finally led to the discovery 
of primary cilia, at the time termed the “central flagella.” (Bloodgood, 2009) The 
first to describe and illustrate (Fig. 2) these structures on mammalian cells in 
1898 was Karl Wilhelm Zimmerman.	    In all, Zimmerman described the “central 
flagellum” on various cell types, including those from kidney tubules, pancreatic 
ducts, thyroid glands, uterine follicles, and seminal vesicles (Bloodgood, 2009). 
While never being able to determine if the structure was motile or not, 
	  5	  
Zimmerman did make several key findings regarding the “central flagellum.” Of 
these, Zimmerman noted that nearly every cell had a “central flagellum,” he 
observed that the structure was always associated with the distal centriole of an 
associated centrosome and that the “central flagellum” was a separate class of 
cilia or flagella from the already described motile cilia and flagella (Bloodgood, 
2009).  
Aside from the discovery and description of the “central flagellum” on 
mammalian cells, however, Zimmerman is most regarded for his correct 
hypothesis, made a century before being shown experimentally, that the 
structure he was observing was likely linked to cellular signaling in some way, 
postulating while studying “central flagella” of kidney tubules that, “changes in the 
configuration of the secretions flowing inside the glandular lumen might have a 
stimulating effect upon the flagellum, whereby the secretory function might be 
qualitatively or quantitatively affected” (Bloodgood 2009, Romero et al., 2001). 
 
Figure 2: The central flagellum. Drawing of one side of rabbit kidney tubule made by Karl 
Zimmerman in 1898. The “central flagella” or primary cilia are depicted as thin lines 
emanating from two black dots at the top of the cells. *Figure adapted from Bloodgood, 
2009 
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Connecting cilium 
 Over the course of the 
following century, the cellular 
importance of the primary 
cilium continued to be debated 
with some groups in the camp 
of Zimmerman, suggesting a 
sensory role for the organelle, 
and many groups believing that 
the organelle was merely a by-
product of evolution (Barnes, 
1961; Munger, 1958; Sorokin, 
1962). An important side step 
in this discussion and one very 
important to retinal biology was 
the use of Electron Microscopy 
(EM) to demonstrate that the 
structure connecting the inner and outer segments of photoreceptor cells was 
actually a modified primary cilium. This was demonstrated in a series of papers 
from Fritiof S. Sjostrand and Eduardo de Robertis. Both experts in EM, Sjostrand 
first published images of retinal rods inner segments in 1953. In analyzing these 
images (Fig. 3) Sjostrand commented extensively on the structure connecting the 
inner and outer segment, noting it contained “16-18 straight fibrils” which he 
Figure 3: The connecting cilium. Left panel- EM 
image taken of a rod photoreceptor by Sjostrand in 
1953 with a black arrow added to point out the 
connecting cilium. Right panel- Sjostrand 
illustration of the structure depicting inner and 
outer segments of the photoreceptor connected by 
the cilium. *Figure adapted from Sjostrand, 1953 
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termed “the connecting fibrils” and that the fibrils entered the inner segment 
where they terminated shortly thereafter (Sjostrand, 1953).  In addition, Sjostrand 
observed that besides the structure containing the connecting fibrils, the inner 
and outer segments of the photoreceptor were, “completely separated,” 
suggesting the architecture of the cell prevented the mixture of each segment’s 
components. In terms of function, Sjostrand hypothesized that the structure 
containing the connecting fibrils was used by the photoreceptor to pass an 
“excitatory state” from the outer segment to the inner segment of the cell after 
sensing light. Three years later, Eduardo de Robertis expanded upon Sjostrand’s 
structural observations when he correctly observed the structure containing the 
connecting fibrils was very similar to a cilium, containing nine pairs of filaments 
anchored at a basal body in the inner segment of the cell. As such, de Robertis 
termed the structure the “connecting cilium” (de Robertis, 1956). 
Intraflagellar transport 
 
At the end of the 20th century, close to 100 years after Zimmerman first predicted 
a sensory function for the primary cilium, Joel Rosenbaum’s laboratory at Yale 
University invigorated the field with the discovery of Intraflagellar Transport (IFT) 
in eukaryotic cilia (Kozminski et al., 1993). IFT, described as the bi-directional 
movement of particles along the flagellar axoneme, was discovered while 
observing flagella of Chlamydomonas reinhardtii by means of differential 
interference contrast (DIC) microscopy and EM. Chlamydomonas, a species of 
single celled green algae, has proven to be an invaluable tool in flagellar and 
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ciliary biology due to the presence of very large flagella, the ability to easily make 
mutant specimens, and the close homology of many of its proteins to mouse and 
human ciliary proteins (Johnson et al., 1993; Pazour et al., 2000). Using DIC 
microscopy (which allows for enhanced contrast of live samples) to study flagella, 
Rosenbaum’s group was able to not only show the movement of particles up and 
down the flagellar axoneme but that the movement actually took place between 
the microtubule axoneme and the flagellar membrane. Further examination of the 
particles by EM verified their location and gave insight into their approximate size 
(Fig. 4).	   In addition, the group was able to track the movement of these particles, 
showing that they moved at a constant pace. Further, the rate of movement 
during flagellar assembly and disassembly was similar to that during movement 
in full-length, stable, flagella, suggesting a maintenance role for the system in 
addition to roles in assembly and disassembly (Kozminski et al., 1993). Further 
work investigating these IFT particles showed they are made up of at least 15 
Figure 4: Intraflagellar transport. DIC image showing particles sandwiched between the 
microtubule axoneme of a Chlamydomonas flagellum with an illustration depicting this 
in the bottom left. *Figure adapted from Kozminski, et al. 1993 
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proteins, divided into two complexes, A and B.  Included in these complexes are 
kinesin-II motors and dynein 1b/2 protein (Pazour and Rosenbaum, 2002).  
Using a previously described temperature sensitive mutant strain of C. 
Rheinhardtii, Rosenbaum and colleagues were able to show that inhibition of the 
kinesin-II motor protein of the IFT complex led to flagellar reabsorption and a 
failure to assemble new flagella (Cole et al., 1998). Work in George Witman’s 
laboratory demonstrated that chlamydomonas containing deletion alleles of the 
dynein 1b/2 protein resulted in short, immotile flagella (Pazour et al., 1998). 
Interestingly, in addition to this phenotype, the flagella were also found to contain 
large amounts of raft-like particles previously described to be associated with the 
IFT complexes (Kozminski et al., 1993; Pazour et al., 1998). Taken together, 
these findings provided evidence that IFT forward, or anterograde, transport was 
likely dependent on kinesin motors while dynein motors were probably 
responsible for reverse, or retrograde, transport. In addition, it was noted that 
when homologues of these proteins in Caenorhabditis elegans (C. elegans) were 
mutated, the cilia of the sensory neurons were observed to be defective, both in 
structure and function (Cole et al., 1998). 
While the discovery of IFT was indeed exceptional, the molecular 
analyses carried out by the Rosenbaum laboratory and others on the individual 
protein complexes of the flagella and cilia have been crucial in delineating the 
protein identity of these structures. It is with these studies that other groups have 
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been able to relate known disease genes with unknown functions to ciliary 
maintenance and health. 
The cilia and polycystic kidney disease- Zimmerman’s prediction verified 
 Shortly after the Rosenbaum laboratory’s first paper on IFT was published, 
Richard Woychik’s group of the Oak Ridge National Laboratory described the 
creation of a transgenic mouse line that demonstrated a phenotype very similar 
to human autosomal polycystic kidney 
disease. The line was created after insertional 
mutagenesis led to a disruption of a gene 
named Tg737 (Moyer et al., 1994). The 
mouse, named Oak Ridge Polycystic Kidney 
(orpk), demonstrated cyst development in the 
collecting ducts of the kidneys, and an inability 
to concentrate urine (Yoder et al., 1996, Yoder 
et al., 1997). While the group extensively 
characterized the phenotype of the mice and 
further mutations in Tg737 in subsequent 
manuscripts, no function for the protein 
associated with Tg737 was found.  
A few years following the development 
of the orpk mice, however, Douglas Cole’s 
Figure 5: orpk mice cilia. SEM 
images of primary cilia on the 
kidney tubules of wild-type mice 
(Top panel) or Tg737 mutant 
mice (Bottom panel). Examples 
of cilia indicated by red arrows. 
*Figure adapted from Pazour, et 
al., 2000 
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laboratory in collaboration with Joel Rosenbaum, George Witman and others 
cloned a Chlamydomonas IFT subunit, IFT88, in order to elucidate its function as 
an IFT particle. Amino acid sequence analysis of IFT88 carried out by the group 
showed that the protein was very likely to be a homologue of both mouse Tg737 
and human Tg737 (Pazour et al., 2000). As IFT88 null chlamydomonas failed to 
form flagella and IFT88 and Tg737, a polycystic kidney-like disease gene, 
appeared to be homologues, the researchers looked at the primary cilia on the 
kidney tubules of both WT and orpk mice. Scanning electron microscopy (SEM) 
analysis of orpk kidney tubules taken from 4 day old mice revealed substantially 
shorter cilia than those of WT mice, measured at around 1um and 3um, 
respectively (Fig. 5)(Pazour et al. 2000). 	   Of note, the orpk mouse is believed to 
carry a hypomorphic mutation in the Tg737 allele, resulting in low but observable 
levels of Tg737-associated protein (Murcia, et al., 2000).  Further studies, 
published by Richard Woychik’s group at about the same time as the IFT88/ 
Tg737 manuscript, of the Tg737 gene show that null mutations result in a much 
more severe phenotype with a failure to develop past mid-gestation due to 
multiple defects, including those in neural tubes and left-right symmetry, and, of 
particular importance, a failure to express the central cilium on ventral node cells 
(Murcia et al., 2000). Taken together, the work done by these labs demonstrated 
for the first time that defects in ciliary health, in this case due to disruption in IFT, 
may lead to human disease.  
An insight into how ciliary health affects kidney health, and the finding that 
validated Zimmerman’s hypothesis, came from Praetorius and Spring a year later 
	  12	  
when they demonstrated that the primary cilium of cultured kidney cells has the 
ability to serve as a mechanoreceptor, potentially sensing flow in kidney tubules. 
Praetorius and Spring observed that when the cilium is bent through being 
pushed by flow or pulled by suction, the cell connected to the cilium responds by 
increasing cellular calcium levels (Praetorius and Spring, 2001). This calcium 
increase was also shown to spread to neighboring cells, likely through gap 
junctions, suggesting that the primary cilia of cells lining the kidney tubules have 
the ability to affect the physiology of not only the cells they are attached to but 
also potentially the tissue as a whole. 
The primary cilium’s first link to development 
 Shortly after the connection was made between ciliary health, specifically 
IFT mutations, and kidney disease, Kathryn Anderson’s laboratory of the Sloan-
Kettering Institute made the observation that mutations in IFT led to defects in 
Hedgehog (Hh) signaling of developing mice (Huangfu et al., 2003).  
The Hedgehog signaling pathway, first described in 1980, is known to be 
crucial for the correct patterning of the neural tube and limb buds during 
embryogenesis as well as development of multiple organ systems (McMahon et 
al., 2003; Wong and Reiter, 2008).  Three Hh genes have been identified in 
mammals to date- Sonic Hedgehog, Indian Hedgehog, and Desert Hedgehog. 
While a role for Desert hedgehog has been identified in spermatogenesis and 
Indian hedgehog appears to function in bone development (Wong and Reiter, 
2008), Sonic hedgehog (Shh) appears most crucial for development as well as 
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continued homeostasis (Chiang et al., 1996; Echelard et al., 1993). Not 
surprisingly, mutations contributing to irregular Shh signaling have been 
implicated in multiple birth defects, including cyclopia, and several cancers 
(Hooper and Scott 2005).  
The Anderson laboratory, while looking for mutations affecting embryonic 
patterning in mice, observed two different mouse mutants, termed wimple (wim) 
and flexo (fxo). The embryonic mice were found to arrest at mid-gestation, 
lacking populations of ventral neural cell types. In addition, the developing heads 
of wim embryos failed to close the neural tube, and fxo mutants demonstrated 
preaxial polydactyly. As these phenotypes are hallmarks of Shh signaling defects 
(Wong and Reiter, 2008) with proper development dependent on concentration 
and time of exposure to Shh ligand, the group began mapping the mutations 
responsible to determine which step of the Hh pathway might be affected. 
Surprisingly, both mutations were mapped to genes associated with IFT. Wim 
was identified as a new mouse homologue of Chlamydomonas IFT172 and fxo 
was determined to be another hypomorphic mouse allele homologous to 
Chlamydomonas IFT88 (Huangfu et al., 2003). Further experiments involving 
these two alleles allowed the group to generate two hypotheses of the role of IFT 
in Hh signaling. The first explanation they developed gives the primary cilium a 
role in the signaling pathway. Recognizing that IFT particles are necessary for 
the development of primary cilia, the authors suggested that a signal originating 
from the cilia might be necessary for proper Hh signaling and without healthy IFT 
particles, the cilia would not be capable of signaling. The other hypothesis they 
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put forward is that cilia actually have no role in the Hh signaling pathway but that 
IFT particles have more than one function- one in developing and maintaining 
cilia and the other in cellular protein trafficking outside of the cilium. The later 
hypothesis suggests IFT particles may be responsible for trafficking Hh proteins 
to the correct cellular location for signaling to occur. 
Shortly after the publication of the Anderson lab’s findings, Jeremy 
Reiter’s group at the University of California, San Francisco provided evidence 
that the first hypothesis was likely correct (Corbit et al., 2005). In doing so, the 
Reiter lab showed a key activator of the Hh pathway, Smoothened (Smo) locates 
to the primary cilium and that ciliary localization of Smo is necessary for 
activation of the Hedgehog pathway (Corbit et al., 2005). 
While linking kidney dysfunction to mutations in ciliary proteins created a 
tremendous boost to the field of ciliary biology, the impact of discovering a crucial 
signaling pathway in human development that was connected to the organelle 
led to heightened interest in studies of this once overlooked structure. Since its 
association with Hh signaling was suggested by the Anderson lab and confirmed 
by the Reiter lab, the primary cilium has been associated with multiple other 
signaling cascades, including wnt signaling and platelet derived growth factor 
(PDGF) signaling, in addition to the previously described mechanosensation in 
the kidney tubules (Lancaster et al., 2011; Schneider, et al., 2005; Praetorius and 
Spring, 2001). 
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A closer look at ciliary formation and structure 
 With a few exceptions, primary cilia are found on the surface of almost 
every quiescent or terminally differentiated cell in the body (Wheatly et al., 1996). 
During cellular replication, however, the pair of centrioles that make up the basal 
body are found away from the membrane and more closely associated with the 
nucleus at the center of the centrosome (Dawe et al., 2007). During cellular 
replication, the centrosome is composed of a mother and daughter centriole 
surround by pericentriolar matrix. The centrioles themselves are barrel-shaped 
Figure 6: Initiation of ciliogenesis. The mother centriole captures a ciliary vesicle after 
an unknown cellular signal. The vesicle elongates before fusing with the cellular 
membrane. *Figure adapted from Garcia-Gonzalo and Reiter, 2012 
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and composed of triplet microtubules, which are arranged in a 9-fold symmetrical 
manner (Prosser et al., 2015). The mother centriole, which is passed on from the 
mother cell to the daughter cell during division, is distinguishable from the 
daughter centriole in that it has distal and sub-distal appendages protruding from 
its sides (Kobayashi and Dynlacht, 2011) with the sub-distal appendages 
appearing to help anchor microtubules to the centriole (De Brababder et al., 
1982; Piel et al., 2000). 
The conversion of the centriole pair from functioning at the centrosome to 
developing into the basal body of the cilium occurs after an unknown signal 
(Kobayashi and Dynlacht, 2011). The first step, however, involves the anchoring 
of the mother centriole to a cellular vesicle (Sorokin, 1962).  The mother centriole 
then begins to nucleate the microtubule shaft, composed of nine, doublet 
microtubules, that eventually becomes the ciliary axoneme and, in doing so, 
invaginates the side of the newly attached vesicle. As the microtubule shaft 
continues to grow, the whole complex begins migrating to the cellular membrane 
where eventually the vesicle surrounding the microtubule shaft fuses with the 
cellular membrane (Fig. 6)(Sorokin, 1962).	    At the membrane, the distal 
appendages of the mother centriole appear to anchor the newly formed basal 
body in place while striated rootlets from the bottom of the basal body can be 
observed extending into the cytoplasm generating further support for the base of 
the cilium (Tachi et al. 1974). Immediately proximal to the basal body, where the 
triplet microtubule formation of the mother centriole changes to a doublet 
formation, the transition zone of the cilia begins. Visible Y-link structures can be 
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seen in the transition zone, which appear to connect the microtubule axoneme to 
the ciliary membrane (Fig. 7).  These links are likely providing further support for 
the structure and potentially 
acting as a diffusion barrier to 
help maintain the proteomic 
identity of the primary cilium 
(Kobayashi and Dynlacht, 
2011; Craige et al. 2010). Past 
the transition zone, the 
axoneme continues, maturing 
into the cilia dictated by the cell 
type. 
Understanding the ciliary proteome- Centrosomal protein 290 kDa (CEP290) 
 While initial studies on the IFT complexes have helped to identify new 
ciliary proteins, link the organelle to multiple signaling pathways, and connect 
mutations in ciliary genes to human disease, our understanding of the proteomic 
identity of the cilia is only just beginning to take shape. Of the three ciliary 
regions, the transition zone remains the least understood, both structurally and 
functionally. One transition zone protein, and the topic of this discussion, that the 
Bennett laboratory has focused on in recent years is Centrosomal protein 290 
kDa (CEP290). First identified from a human brain cDNA library in 1997 (Nagase 
et al., 1997), CEP290 has been shown to localize to multiple cellular locations 
Figure 7: Y-links. Cross-section illustration of the 
Y-links at the transition zone, immediately 
proximal to the top of the mother centriole/ basal 
body. *Figure adapted from Basten and Giles, 
2013 
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depending on cell type and cell cycle phase. These locations include the 
centrosome, specifically the distal ends of each centriole (Tsang et al., 2008), 
during interphase (Valente et al., 2006), the basal body during G0 (Gordon et al., 
2008), the pericentriolar matrix particles (Kim et al., 2008), and the transition 
zone of chlamydomonas flagella and mammalian connecting cilia (Craige et al., 
2010, Cideciyan et al., 2007). Of utmost importance, Brian Dynlacht’s group at 
New York University’s school of medicine demonstrated that siRNA knockdown 
of CEP290 mRNA in cells suppressed the formation of primary cilia. 
 Localization of CEP290 to the transition zone of mammalian 
photoreceptors is specifically important to the Bennett laboratory, due to our 
interest in Leber Congenital Amaurosis (LCA). LCA is an early onset, retinal 
degenerative disease, typically causing severely impaired vision first recognized 
in infants and young children. What little vision the patients have early in life, is 
lost due to the degenerative nature of the disease. Of all known LCA cases, 
mutations in CEP290 are believed to be account for over 20% of cases of LCA. 
In addition to retinal disease and very characteristic of ciliary genes, mutations in 
CEP290 are also associated with a spectrum of other diseases, including Senior 
Loken Syndrome, Joubert Syndrome and Joubert Syndrome Related Disorders, 
as well as Meckel-like and Meckel Gruber Syndrome (den Hollander et al., 2006; 
Genetics Home Reference, 2015; Brancati et al., 2007; Genuardi et al., 1993; 
Ahdab-Barmada and Claassen, 1990). These disease states are all classified as 
ciliopathies due to the observation that inflicted patients have defects in ciliary 
health. 
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Structure 
 Human CEP290 is a relatively large protein, composed of 54 exons with 
an open reading frame of approximately 7.9 kb and molecular weight of 290 kDa 
(Tsang et al., 2008; Guo et al., 2004). The amino acid sequence is known to 
encode 13 coiled-coil domains, making up over 60% of the protein (Guo et al., 
2004; Sayer et al., 2006) In addition, the protein contains a region of sequence 
similarity to Structural Maintenance of Chromosomes (SMC) chromosome 
segregation ATPases, three tropomyosin homology domains, six KID motifs, an 
ATP/GTP binding site motif A (P-loop), and a nuclear localization signal (Sayer et 
al., 2006). 
Function 
Most of our knowledge related to CEP290’s potential function in the cell is 
speculative through observing its interaction with other cellular and ciliary 
proteins. In 2010, however, George Witman’s laboratory published a study using 
chlamydomonas to identify a potential ciliary role of CEP290 for the first time.  
Like many ciliary proteins, CEP290 is highly conserved across species, including 
between humans and chlamydomonas (Craige et al., 2010).  Using EM, 
Witman’s group was able to show that CEP290 localized to the transition zone of 
the flagellum (Craige et al., 2010). Cross-sections of the structure allowed the 
localization to be determined at higher resolution with antibodies specific to 
CEP290. These studies showed the protein’s position on or adjacent to the Y-
link, a position where it could help secure the relationship of the ciliary axoneme 
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and membrane (Craige et al., 2010)(Fig. 8). Interestingly, further analysis of 
Cep290 mutant flagella by EM showed that the transition zone Y-links were 
almost completely absent (Fig. 9), suggesting CEP290 may contribute to these 
Y-links and thus, flagellar and ciliary stability.  
The flagella of cep290 mutants were characterized to be very short with 
some observed to elongate with time. Examining these short flagella by EM, the 
group noticed points where the membrane seemed to bulge around areas of high 
electron density, a phenotype observed in chlamydomonas lacking proteins 
associated with retrograde IFT.  Analyzing these flagella by western showed 
mutant flagella to contain uncharacteristically high levels of IFT complex B 
proteins and low levels of IFT complex A proteins. However, through monitoring 
Figure 8: CEP290 localization. 
Localization of HA-tagged CEP290 
at the flagellar transition zone. Left 
panned shows a longitudinal view 
of the transition zone. Right panel 
shows a cross-section. Larger 
dots correspond to anti-CEP290 
staining while smaller dots are 
associated with anti-HA staining. 
*Figure adapted from Craige et al., 
2010. 
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the IFT activity by DIC, both anterograde and retrograde trafficking was normal.  
As one hypothesized 
role of CEP290 is that it 
forms a diffusion barrier 
at the base of the cilium, 
the group also analyzed 
the flagellar levels of 
other known ciliary 
proteins, finding mutant 
cilia to be enriched in 
some proteins and 
completely lacking 
others. These findings 
suggested CEP290 
might in fact serve as a 
diffusion barrier, a 
function distinct from its IFT function. 
Recently, the Bennett laboratory has extended these findings to human 
CEP290, identifying both a microtubule binding region of the protein as well as a 
membrane binding region through a series of immunofluorescence and 
biochemical experiments (Drivas et al., 2013). These regions are likely critical for 
CEP290’s roles in the cell. 
Figure 9: Comparison of Y-links. Y-links visible in WT 
flagella appear compromised or absent in mutant 
cep290 flagella. Inset images in C and D show 
magnified examples of the areas typically composed of 
the Y-links. *Image adapted from Craige et al., 2010 
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While a cellular role for CEP290 is beginning to be defined, our 
understanding of the variable pathogenesis resulting from CEP290 mutations 
remains limited. Guided by many of the previously reported findings described 
above and a relatively defined patient population, I sought to determine a 
mechanism by which CEP290-associated disease could be explained. 
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CHAPTER 2- Model of CEP290-associated disease pathogenesis 
 
As mentioned previously, mutations in CEP290 are associated with a 
spectrum of disease states including Leber congenital amaurosis (LCA), Senior-
Loken syndrome (SLS), Joubert syndrome (JS), Joubert syndrome-related 
disorders (JSRD), Meckel-like syndrome (ML), and Meckel Gruber syndrome 
(MKS). All of these diseases are classified as ciliopathies due to deficits in ciliary 
structure and/or function that patients with these diseases suffer. While mutations 
in CEP290 can lead to any one of these diseases, why one mutation leads to 
LCA and another mutation is associated with MKS has previously been 
unexplained. In trying to understand this, I began to wonder if perhaps the 
location of the mutation in the open reading frame that encodes each protein was 
also playing a role in the pathogenesis of associated disease. Using a 
combination of published CEP290 genotypes and phenotypes as well as cell 
lines generated from a population of CEP290 patients, I, together with Theodore 
Drivas explored this thought, eventually proposing a model of disease 
pathogenesis whereby disease severity was associated with level of functional 
CEP290 protein. Specifically, I hypothesized that mutations predicted to result in 
low levels of protein would lead to more severe disease phenotypes than 
mutations predicted to result in higher relative levels of protein. 
Leber congenital amaurosis, first described by Theodor Leber in 1869, is 
an autosomal recessive form of retinal degeneration, which typically leads to 
severe visual deficits early in life (Perrault et al., 2010). Considered the most 
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severe of inherited retinal dystrophies because of its early onset, mutations in at 
least 18 different genes can lead to LCA. Included in this set is Retinal Pigment 
Epithelium-Specific Protein 65 kDa (RPE65) in which the disease is classified as 
LCA2, nicotinamide monocucleotide adenylyltransferase 1 (NMNAT1) in which 
the disease is classified as LCA9 (Koenekoop et al., 2012), and CEP290 in which 
the disease in classified as LCA10 (den Hollander et al., 2006). The common 
symptom in all LCA patients is retinal disease.  
Patients afflicted with Senior-Loken syndrome suffer from both retinal 
involvement as well as severe kidney disease. SLS is also an autosomal 
recessive disease, with roughly one in 1,000,000 people affected worldwide. 
Kidney disease in SLS patients takes the form of cyst development early in life, 
which typically leads to renal failure by adolescence (Genetics Home Reference, 
2015). In addition to CEP290, there are currently five other known SLS disease 
genes. 
 Mutations associated with Joubert Syndrome lead to hypotonia, ataxia, 
oculomotor apraxia, and additional symptoms due to a malformation, hypoplasia 
or aplasia of the cerebellar vermis, in the patient’s midbrain-hindbrain region. 
This finding is detected through magnetic resonance imaging and is termed the 
“molar tooth sign” (Brancati et al., 2007). In addition to this classical 
representation of JS, patients with JSRDs present with additional disease 
manifestations including findings associated with LCA and SLS. Most patients 
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with CEP290-associated JS fall into the category of having a JSRD with retinal 
and kidney involvement (Brancati et al., 2007). 
Meckel-like and Meckel Gruber Syndrome fall into the most severe end of 
the spectrum of CEP290-associated disease. These autosomal recessive 
diseases affect multiple organ systems including the eyes, kidneys, brain, liver, 
skeletal, and reproductive system (Ahdab-Barmada et al., 1990). Fetuses 
afflicted with MKS rarely survive past birth and those babies that do generally die 
within the first few months due to respiratory difficulties or kidney failure. ML 
patients have been reported to live slightly longer, with one patients reported to 
have survived until 43 months of age (Genuardi et al., 1993). 
 While it is accepted that the illness of CEP290 patients who fall into this 
spectrum of diseases is due to the role that CEP290 plays at the primary cilium 
across multiple cell types, there has been much speculation attempting to explain 
the pleiotropic nature of CEP290-associated disease. As many mutations in 
CEP290 are classified as nonsense mutations, it is tempting to speculate that the 
observed disease spectrum is associated with severity of a truncation. In this 
model, nonsense mutations that led to more severe truncations and shorter 
protein fragments would result in more severe disease. Due to nonsense-
mediated decay (NMD), however, nonsense mutations rarely lead to the actual 
translation of truncated protein (Maquat, 2004), and even so, the nonsense 
mutations observed in CEP290 patients would not fall into this model.  
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Another potential explanation of variable CEP290-associated phenotypes 
is the role that modifying alleles could play in determining eventual disease. In 
this model, there would be both a mutation in CEP290 and a mutation in a 
different gene. This hypothesis was tested by Val Sheffield’s laboratory at the 
University of Iowa. In this study, the group crossed mice homozygous for a partial 
deletion mutation in Cep290 with mice that were homozygous null for a gene 
encoding a member of the BBSome protein complex, a complex known to 
interact with Cep290 at the transition zone and centriolar satellites (Zhang et al., 
2014). From this cross, the group observed that mice homozygous for both 
mutations had more severe disease than mice with just mutations in Cep290. In 
addition, mice homozygous for the Cep290 mutation but heterozygous for the 
BBSome mutation were observed to have less severe disease than the double 
homozygous mutants but still more severe disease than mice with only mutations 
in Cep290. While this is a very interesting finding and modifying alleles likely play 
a part in the phenotypic diversity of many disease states, this model becomes 
very complicated when dealing with a protein such as CEP290, which is linked to 
multiple known, and likely more unknown, interacting partners. 
The goal of my work was to determine a genotype to phenotype 
correlation using only mutations in CEP290 and the associated disease states 
observed in patients.  To this end, I took advantage of recently published findings 
(den Hollander et al, 2006; Littink et al., 2010) as well as a database of CEP290 
genotypes and phenotypes generated by Frauke Coppeiters, Steve Lefever, Bart 
Leroy, and Elfride De Baere at Ghent University Hospital (Coppieters et al., 
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2010) to formulate a model in which the spectrum of observed CEP290-
associated phenotypes may be explained by considering the effect of basal 
amounts of exon skipping of disease and wild-type alleles.  
As mentioned previously, many of the mutations observed in CEP290 
patients are nonsense mutations, resulting in an early stop codon and likely 
leading to degradation of the mRNA message by nonsense-mediated decay 
(NMD) (Fig. 10). The most prominent mutation, c.2991+1655A>G, is a mutation 
in Intron 26 that leads to the insertion of a cryptic exon (den Hollander et al, 
2006). Inclusion of the cryptic exon in the message also leads to a premature 
stop codon. This mutation became of interest to us because it is actually skipped 
about 50 percent of the time, leaving a wild-type message encoding full-length 
protein. As such, the mutation leads to the production of about half the protein 
compared to that produced by a wild-type allele. In addition to this well reported 
example of CEP290 exon skipping, the den Hollander group at Radbound 
University Nijmegen recently described a CEP290 nonsense mutation that 
induced exon skipping, leading to previously undescribed, near-full-length 
CEP290 isoforms (Littink et al., 2010). 
Our current understanding of CEP290’s role in the cell is that, in addition 
to potentially forming a diffusion barrier at the base of the cilium, CEP290 
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appears to act as a stabilizing structure, helping to link the microtubule axoneme 
of the cilia with the surrounding membrane (Craige et al., 2010, Drivas et al., 
2013) (Fig. 11). As one role of the protein appears to be connecting one structure 
Figure 10: Reported CEP290 mutations. A majority of mutations in CEP290 are 
classified as frame shift or nonsense mutations. Mutations labeled with asterisks likely 
disrupt the start codon, potentially resulting in near normal levels of near-full-length 
protein after initiation of translation at the downstream AUG codon. *Figure adapted 
from Drivas and Wojno et al., 2015 
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to another, perhaps an isoform with one less exon could still achieve this task. In 
addition, if stabilization, and in turn health, of the cilia determines disease, even a 
slight increase in the amount of cellular CEP290, full-length or near-full length, 
available to help stabilize the cilia may be enough to preserve its function in a 
given cell type.  To hypothesize a mechanism by which this might be feasible, 
one might consider two nonsense mutations located in two different exons of 
CEP290, one exon which can be skipped while still maintaining reading frame of 
the protein and the other exon that can not be skipped without altering the 
reading frame. As it is known that the fidelity of the splicing machinery is not 
100% (Howe et al., 2003; Solis et al., 2008) and it has been suggested that 92-
94% of human genes are subjected to alternative splicing (Wang et al., 2008), 
perhaps minimal but relevant amounts of near-full-length CEP290 will still be 
translated from the allele containing a nonsense mutation in an exon that can be 
Figure 11: Illustration of one proposed role for CEP290 at the base of the cilium. In this 
model, Wild-type CEP290 is capable of binding the microtubule axoneme of the primary 
cilium to the cellular membrane. Mutant CEP290, however, may be unable to carry out 
this task due to various changes in the protein caused by mutations. 
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skipped. In contrast, no protein (full length or near-full-length) would be produced 
from the allele carrying a nonsense mutation that cannot be skipped (Fig. 12) 
without altering the reading frame of the protein. 
 While the amount of protein produced from randomly splicing out the exon 
containing the mutation on the allele would be expected to be rather minimal and 
not capable or rescuing the patient from disease altogether, maybe it is enough 
to rescue the patient from the most severe disease states. That is, in a patient 
with a nonsense mutation in an exon that can be skipped, successful read 
through of the splicing machinery would result in small amounts of near-full-
length protein that ameliorates disease. In contrast, in a patient with a nonsense 
mutation in an exon that cannot be skipped, no protein would be produced, 
leading to an exacerbation of disease (Fig. 13). 
  
Figure 12: Proposed Model. Potential model by which low levels of near-full-length protein 
could be encoded by a disease allele containing a nonsense or frame shift mutation. On 
the left, a disease allele contains a nonsense mutation in an exon that can be skipped 
while still maintaining the reading frame of the protein. As a result, most mRNA message 
will likely be degraded through NMD (example I), however, translation of the exon-2-
skipped transcript (example II) may lead to the production of a small amount of near-full-
length protein. In examples III and IV, a nonsense mutation on a disease allele falls into an 
exon that can not be skipped without altering the reading frame of the protein. Both the 
original mutation-containing message and any potential exon-skipped exons are likely 
degraded. *Figure adapted from Drivas and Wojno et al., 2015 
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The thought that variable amounts of protein could lead to differing 
degrees of phenotype severity is not new and, as previously discussed, was 
actually made during the initial IFT studies in mice.  In these studies, it was 
observed that null mutations in the IFT88 homologue resulted in very severe 
developmental defects with the mice not surviving to birth. While still deadly, the 
phenotype of mice with hypomorphic mutations in the same gene was 
determined to be less severe due to small amounts of protein product being 
translated. This allowed the mice to survive for a few weeks before eventually 
succumbing to disease (Pazour et al., 2000).  
With the newly developed model in mind, all classified all known CEP290 
mutations were classified into categories based on the prediction of the individual 
Figure 13: Model to explain the pleiotropic nature of CEP290 mutations. The model 
suggests that CEP290 mutations in exons that can be skipped may result in small 
amounts of near full-length protein, depicted in the middle frame. While these levels 
would not be enough to escape disease completely, they might contribute to a less 
severe disease phenotype as is depicted by no cilium formation in the right panel. 
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mutation’s effect on the total amount of CEP290 in the cell (Fig. 10). In doing so, 
missense mutations were predicted to have a minimal effect on CEP290 levels. 
Therefore, they were classified as mild mutations. In addition, as the CEP290 
intron 26 mutation has been found to produce roughly 50% the protein of a wild-
type allele (den Hollander et al., 2006), we categorized this mutation as mild, as 
well. Meanwhile, nonsense or frame shift mutations that fell in exons that could 
be skipped, potentially producing near-full-length protein (even if at low levels), 
were classified as moderate. Mutations falling in exons that could not be skipped 
without disrupting the reading frame of the protein, and which would not lead to 
production of any protein, were classified as severe (Fig. 10). 
 After classifying reported mutations based on the prediction of their effect 
on CEP290 protein levels, we began to correlate the genotypes and phenotypes 
of individual patients with CEP290 mutations to test the hypothesis. To do so, the 
CEP290 alleles of each patient were determined to be mild, moderate, or severe. 
Patients with a mild mutation on each allele were predicted to have relatively high 
amounts of CEP290 protein and therefore, the least severe disease, (i.e. LCA, 
with retinal findings, only). Patients with one mild and one moderate or severe 
mutation were predicted to have slightly less relative amounts of CEP290 protein. 
With the decrease in predicted protein levels, those patients were predicted to be 
afflicted with more severe disease, including SLS. Meanwhile, patients with two 
moderate mutations were predicted to generate low levels of CEP290. Thus, it 
was predicted that their phenotypes would fall into even more severe disease 
states yet, including JS and JSRD in addition to SLS. Finally, patients with alleles 
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classified as either moderate/severe or severe/severe were predicted to produce 
relatively little protein or no protein at all. These patients were predicted to be in 
the most severe end of the disease spectrum with phenotypes in the 
moderate/severe group including SLS, JS, JSRD, and ML and phenotypes in the 
severe/severe group including JSRD, ML, and MKS (Fig. 14).  
In applying the actual phenotypes of the patients to our prediction of their 
relative CEP290 protein levels and hypothesizing that the predicted protein 
amounts produced by a given patient’s CEP290 alleles might correlate with their 
observed disease severity, we found the predicted protein amounts were indeed 
significantly associated with a given patient’s phenotype (P<0.0001, Fisher’s 
exact test) (Fig. 15).  Of those patients with an LCA phenotype, 90 percent were 
predicted to have medium to high levels of CEP290. Meanwhile on the other end 
of the disease spectrum, all ML or MKS patients were predicted to have low to 
absent levels of CEP290. In between these two extremes, the level of predicted 
Figure 14: Classification of CEP290 genotypes. Each allele was assigned a severity 
classification. The classifications were used to predict protein levels and 
phenotype. *Figure adapted from Drivas and Wojno et al., 2015 
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protein varied as might be expected, with slightly higher levels weighted to the 
less severe phenotypes and slightly lower predicted levels falling towards the 
more severe end of the spectrum.  
 While the reported genotypes and associated phenotypes appeared to fit 
nicely into the model, the phenotypes of 32 of the 250 patients analyzed from the 
literature were more severe than we would have predicted based on their 
genotypes. That is, while we predicted those patients to have low levels of near-
full-length protein with phenotypes in the middle of the spectrum, their 
phenotypes actually fell into the most severe group. In looking closer at these 
cases, it was noted that 23 of the 32 patients had mutations that clustered in two 
regions of CEP290, exons 6 and 9 in the N-terminal region and exons 40 and 41 
towards the C-terminal portion of the protein (Fig. 16). Mapping the location of 
these two regions on CEP290 shows that they fall in two domains that are likely 
Figure 15: Predicted CEP290 protein level of patients grouped with actual phenotype. In 
general, patients who are predicted to have higher amounts of protein are observed to 
have less severe disease. *Figure adapted from Drivas and Wojno et al., 2015 
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critical for the function of the protein. The first involves the N-terminal region of 
CEP290, which confers membrane binding. The second is closer to the C-
terminal and is necessary for binding microtubules (Drivas et al., 2013).  While 
speculative, the case might be that although we predicted these mutations to be 
moderate, producing low amounts of near-full-length CEP290, these particular 
isoforms may be totally devoid of function due to lack of a key domain. Even if 
these patients were expressing low amounts of near-full-length CEP290, the lack 
of function of the protein might push their phenotypes to the most severe end of 
the spectrum. In taking these assumptions into consideration, we reclassified the 
23 mutations from moderate to severe. Reapplying the phenotypes of the 
patients to our predicted levels of their functional CEP290, the data showed that 
predicted protein levels were again significantly correlated with disease 
phenotype (p<0.0001, Fisher’s exact test) (Fig. 17). Of note, no MKS patients 
were predicted to have any functional CEP290. 
Figure 16: Illustration of the CEP290 coding region. Depicted are domains observed to 
be important for membrane binding and microtubule binding as well as mutations that 
fall in these domains. *Figure adapted from Drivas and Wojno et al., 2015 
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 To confirm our findings, I wanted to determine if we could detect the 
predicted isoforms in CEP290 patient samples. To do this, we obtained seven 
primary dermal fibroblast cell lines, each generated from skin biopsies taken from 
CEP290 patients at the Stephen A. Wynn Institute for Vision Research of the 
University of Iowa. In addition to the cell lines, detailed phenotype information of 
each patient was also provided. This information was collected by a single 
clinician who was masked to the genotypes of the patients (Fig. 18). 
 Six of the seven patients were predicted to have high to medium levels of 
CEP290 protein and all of these patients had a phenotype of LCA (i.e., retinal 
disease only). One patient, however, was predicted to have no functional levels 
Figure 17: Predicted functional CEP290 protein levels. The predicted functional level of 
protein in patients grouped with actual phenotypes. Patients with higher amounts of 
predicted functional protein are observed to have less severe disease phenotypes. No 
MKS patients are predicted to have any functional CEP290. *Figure adapted from Drivas 
and Wojno et al., 2015 
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of CEP290 due to two nonsense mutations, one in exon 17 and one in exon 41. 
This patient had been diagnosed with Joubert syndrome and retinal dystrophy, 
the most severe phenotype of the group. (Fig. 18)  
 The first goal with these cell lines was to determine if the relationship 
between our predictions regarding the relative amount of protein in the cells and 
actual, measured amounts in samples held true. To do so, we analyzed the 
amount	  of CEP290 in each of the cell lines and compared these amounts to three 
wild-type controls. Confirming our predictions, the highest amount of CEP290, at 
roughly 50% of wild-type levels, was observed in the cells generated from patient 
54, who we predicted would have the highest amount of CEP290 protein due to 
having two mild CEP290 mutations (Fig. 19). In addition, CEP290 amounts 
isolated from the cells of patients that we predicted to have medium levels of 
Figure 18: Genotypes, phenotypes, and clinical information of seven CEP290 patients. 
Color-coding as in Figure 14. Orange with red stripe overlay signifies mutations 
expected to produce low levels of CEP290 lacking exon 6 or 41. FS, frameshift; S, 
premature stop codon; VF, measurable visual fields; VFNA, visual fields not able to be 
measured, light perception only; NLP, no light perception; ID, Intellectual disability; 
NOD, no overt disease. *Figure adapted from Drivas and Wojno et al., 2015 
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protein were all observed to be lower than those observed in patient 54 but still 
around 33% of wild-type levels. Of particular interest, however, was the amount 
of CEP290 observed in the cells isolated from patient 582. Despite two nonsense 
mutations (one skippable but likely resulting in non-functional protein), a small 
amount of CEP290 (8.5% of wild-type levels) was observed in these cells. This 
finding is contrary to traditional models of nonsense mutations that would dictate 
no full-length or near-full-length levels of protein in these cells due to either 
Figure 19: Observed CEP290 levels. Predicted CEP290 protein levels of the patients and 
three controls correlates with observed protein expression by western blot. Top panel- 
Primary dermal fibroblasts associated with each patient and three controls were lysed 
and protein run by SDS-PAGE. Bands associated with CEP290 were observed around 
290 kDa. Loading control alpha-tubulin was also probed in each lysate. Bottom panel- 
Densitometric analysis of blot in top panel. *Figure adapted from Drivas and Wojno et 
al., 2015 
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truncation of the protein or degradation of the message by nonsense mediated 
decay.  
We next sought to determine if the isoforms that our model predicted 
could be detected in the patient isolated cell lines. To correlate this, we 
generated custom polymerase chain reaction (PCR) assays for each isoform of 
interest. These included isoforms lacking exon 6, exon 10, exon 41, and exon 46, 
exons that could be skipped without altering the reading frame. Complementary 
DNA (cDNA) generated from the RNA isolated from the patient specific cell lines 
was used as the template of the PCR reactions. We attempted to isolate the 
exon 6 skipped isoform using cDNA from patient 182, the exon 10 skipped 
isoform using cDNA from patient 62, the exon 41 skipped isoform using cDNA 
from patient 582, and the exon 46 skipped isoform using cDNA from patients 619 
and 620. In addition, cDNA isolated from wild-type control fibroblasts was also 
used as a template for each assay. The assays were designed to amplify the 
isoform using a three primer approach, as depicted with W-X-Y-Z signifying a 
wild-type message and with exon X as the skipped exon (Fig.20). As illustrated, 
two forward primers were designed. The first primer (P1) was designed to sit at 
Figure 20: Isoform detection using a three-primer PCR approach. Exon X signifies the 
exon to be skipped. *Figure adapted from Drivas and Wojno et al., 2015 
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the hypothetical W-Y junction, which should only be present in isoforms lacking 
exon X. A second forward primer (PC) was designed with a 3’ portion 
complementary to the 5’ portion of exon Y and a scrambled sequence making up 
the 5’ portion of the primer.  This primer serves as the control of the reaction. 
Finally, a reverse primer was designed to a downstream exon to create an 
amplicon of roughly 200 bp. Using this approach and the cDNA from the patient 
derived fibroblasts as well as control cDNA, we were able to isolate the predicted 
isoform in each assay using both the patient-specific and control cDNA (Fig. 21). 
Of note, observing the isoforms in the control cDNA led us to conclude that the 
exon skipping we were observing was not influenced by an effect of each 
mutation, as is the case with nonsense-induced alternative splicing (Cartegni et 
al., 2002). Rather, the skipped isoform seemed to be another member of the 
cDNA population, potentially due to infidelity of the splicing machinery. As such, 
we termed the process by which these isoforms are produced as Basal Exon 
Skipping. 
Figure 22: Quantification of isoform levels. TaqMan qPCR was used to quantitatively 
measure isoform levels in patient and control samples. Probe designed to sit on 
hypothetical border created by skipped exons. *Figure adapted from Drivas and Wojno 
et al., 2015 
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 After observing the isoforms through traditional PCR, TaqMan qPRC 
assays were designed for each exon-skipped isoform in an effort to quantitatively 
analyze their presence in the 
cDNA population. The probe 
of the TaqMan assay was 
designed to sit at the 
hypothetical W-Y border with 
upstream and downstream 
primers specific to the exons 
of each particular isoform	  as 
illustrated (Fig. 22).	    As our 
standard PCR approach 
suggested the isoforms were 
not mutation-specific but 
likely part of the normal 
cDNA population, we 
attempted to measure the 
level of each isoform in the 
lysates of all patients-specific 
cells and controls. As expected, isoforms lacking exons 6, 10, 41, and 46 were 
detected in all cell lysates and levels are depicted as a percentage of those 
observed in the control sample after all values were normalized to GAPDH (Fig. 
23). In most cases, the amount of all skipped isoforms in each sample seemed to 
Figure 21: Isoform detection in patient and control 
cDNA samples. Isoforms were detected in exon 6, 
10, 41, and 46-skipped transcripts in both patients 
and controls. *Figure adapted from Drivas and 
Wojno et al., 2015 
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be correlated with total CEP290 transcripts, supporting our model that a 
population of isoforms is likely produced through randomness of the splicing 
machinery.  When analyzing the amount of skipped isoform specific to a given 
patient (such as exon 10-skipped isoforms for patient 62), however, we would 
have expected to see enrichment of that isoform compared to total CEP290 
levels. For example, in regards to exon 10-skipped isoforms, transcripts 
containing the nonsense mutation in exon 10 would likely be degraded by NMD 
while those isoforms skipping the mutation should survive and make up a larger 
percentage of total CEP290 transcripts in the cell. To analyze this further, we 
normalized the level of each exon-skipped CEP290 transcript to total CEP290 
transcript level in each patient (Fig. 24). This analysis showed an almost 6-fold 
increase of exon 41-skipped transcript relative to total CEP290 transcript levels in 
patient 582, whose genotype includes a nonsense mutation in exon 41. While 
similar increases in skipped isoforms associated with the genotypes of the other 
patients were not observed, it should be noted that the genotypes of the other 
patients all included the mild intron 26 mutation, potentially concealing the 
Figure 22: Quantification of isoform levels. TaqMan qPCR was used to quantitatively 
measure isoform levels in patient and control samples. Probe designed to sit on 
hypothetical border created by skipped exons. *Figure adapted from Drivas and Wojno 
et al., 2015 
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relative increase in skipped isoform through elevated levels of total CEP290 
transcript. 
	   Taking into account the results presented here, we concluded the model 
may be one way to explain the pleiotropic nature of CEP290-associated 
phenotypes. However, to confirm the generality of the result, we sought 
confirmation that a similar process could affect the genotype/phenotype 
relationship with another protein. To investigate this, we selected another ciliary 
gene/protein to study: coiled-coil and C2 domain containing 2A (CC2D2A). 
CC2D2A was recently described as necessary for the successful assembly of 
sub-distal appendages which in turn aid in vesicle docking and anchoring of 
Figure 23: Comparison of isoform levels. Expression of full length CEP290 and exon-
skipped isoforms was determined for each patient and control. Relative expression for 
each transcript was determined using the ΔΔCt method normalizing to GAPDH and 
adjusting transcript to percent of that observed in the control (C1). *Figure adapted 
from Drivas and Wojno et al., 2015 
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microtubules to the mother centrioles (Veleri et al., 2014). Like CEP290, 
mutations in CC2D2A lead to a spectrum of disease states, including JS, JSRD, 
and MKS. In addition, many of these mutations are nonsense mutations. Unlike 
CEP290-associated disease, a relatively large number of CC2D2A mutant 
patients have JS without further symptoms associated with JSRDs. As such, we 
were able to separate the disease states into three phenotypic groups. In 
applying the gathered patient genotypes and phenotypes, our model again fit the 
patient population, with predicted CC2D2A protein expression correlating with 
severity of disease (P<0.0001, Fisher’s exact test) (Fig. 25).  Further refinement 
of this relationship in CC2D2A, as was undertaken for CEP290, however, is 
made difficult by a few factors. First, our understanding of structural and 
Figure 24: Exon 41-skipped isoforms. Exon 41-skipped isoforms in cDNA of patient and 
control fibroblasts determined by TaqMan PCR. Data normalized to total CEP290 
transcript level and adjusted to percent of normal control (C1) using the ΔΔCt method. 
Data presented as means +/- SD (n=3). Asterisk marks significantly different mean from 
other, P<0.0001. *Figure adapted from Drivas and Wojno et al., 2015 
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functional domains in CC2D2A is relatively limited outside of an observed C2 
domain near the C-terminal end of the protein (Tallila et al., 2008). In addition, 
the number of patients and 
described mutations is 
much smaller than that of 
CEP290, currently making 
outliers difficult to spot. 
Finally, CC2D2A-
associated disease 
appears to be much more 
severe than that witnessed 
in CEP290 patients, 
narrowing the spectrum of 
phenotypes observed to more detrimental disease. It will be interesting to monitor 
this disease group, however, as the number of described genotypes and 
phenotypes increases to determine if important domains of the protein might be 
implicated by their failure to follow the proposed model. 
 Recently, in an effort to determine if these spliced isoforms could be 
detected in other cell types, cDNA isolated from wild-type human retinal tissue 
was analyzed for exon 10-skipped isoforms. Reactions using either cDNA from 
dermal fibroblasts, as before, or retina were run side-by-side, resulting in the 
isolation of exon 10-skipped isoform from both samples (Fig. 26).  
Figure 25: Application of the model to CC2D2A 
patients. Predicted protein levels in CC2D2A patients 
correlate with disease severity. *Figure adapted from 
Drivas and Wojno et al., 2015  
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Discussion 
The results of this portion of my studies provide an explanation for the 
observed pleiotropy caused by two ciliary disease genes, CEP290 and CC2D2A. 
While the model offers an explanation for observations that have proven quite 
puzzling over the years, the suggested mechanism by which this model works 
may be just as interesting. Basal amounts of exon skipping, dictates that 
heterogeneous populations of mRNA isoforms in the body may lead to small 
populations of near-full-length proteins, which in many cases may retain some of 
the function provided by the wild-type form. It is important to note that we are 
predicting the levels of these isoforms to be very small, compared to the wild-
type message. In fact, initial studies utilizing an RNAseq approach did not detect 
the isoforms that we present here, potentially due to an inability to detect minimal 
levels of alternatively spliced isoforms from an already low number of reads 
through individual CEP290 splice junctions. However, while small and without the 
ability to totally eliminate disease, this heterogeneous population of protein may 
Figure 26: Detection of exon-skipped isoform in WT retina. cDNA isolated from 
either WT dermal fibroblast (lane 1,2) or WT retina (3,4) was used to probe for the 
presence of exon 10-skipped isoform. Reactions ran in lanes 1 and 3 used the 
experimental primer set for exon 10-skipped isoforms, and reactions run in lanes 2 
and 4 used the control primer set for exon 10-skipped isoforms described in Fig. 
20. 
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be sufficient to rescue patients from the most severe form of disease when 
composed of the correct isoforms. Further investigation will be needed to 
determine if there are other diseases in which this mechanism provides global 
rescue. While alternatively spliced isoforms have been implicated in disease 
through the production of dominant-negative proteins (Solis et al., 2008), 
investigations into the positive benefits of alternatively spliced isoforms have 
been relatively overlooked- likely due to a lack of studies analyzing the mRNA 
populations of healthy individuals related to disease.  
 While we believe this model provides a potential explanation to the 
pleiotropic nature of CEP290 and CC2D2A- associated disease, our studies were 
limited in a few aspects. First, we have applied this model to all tissues and cell 
types associated with CEP290 disease while only attempting to detect CEP290 
isoforms in the cDNA of the primary dermal fibroblasts and whole retina that were 
available. While, exon skipping and alternative splicing has previously been 
reported in several tissue types (Wang et al., 2003), including human retina 
(Littink et al., 2010), detection of CEP290-specific isoforms in all tissues 
associated with CEP290 disease would indeed strengthen our claims. In 
addition, an increase in the number of reported CC2D2A patients and an 
increase in the diversity of described mutations for this gene would definitely 
strengthen its association with this model and allow for further investigations of 
the protein, potentially using the model as a guide. Finally, determining if this 
model holds true to other pleiotropic disease genes, both ciliary and not, would 
be of great benefit.  
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Materials and Methods 
Study Design 
Review of CEP290 and CC2D2A genotype/phenotype relationships was 
carried out using published data (see below). Additional genotype/phenotype 
data were collected from patients seen at the retinal degeneration clinics at the 
Center for Advanced Retinal and Ocular Therapeutics and from the Stephen A. 
Wynn Institute for Vision Research. Genotyping was carried out at the John and 
Marcia Varver Nonprofit Genetic Testing Laboratory, University of Iowa. Tissue 
samples were also collected from patients seen at both centers using protocols 
approved by the respective Institutional Review Boards (IRBs). Molecular 
Genetic testing of the samples was carried out to determine transcript and 
protein expression as described below. Results of molecular genetic testing were 
correlated with the predictions based on review of genotype/ phenotype data. 
Mutation analysis 
Human mutations in CEP290 were compiled from published articles and 
from the CEP290 mutation database developed by F. Coppieters, S. Lefever, B. 
P. LeRoy, and E. De Baere at Ghent University and Ghent University Hospital, 
Ghent, Belgium (19). The coding effect of each mutation was noted, particularly 
with respect to whether an exon was predicted to be disrupted by a premature 
stop codon (because of either nonsense or frameshift mutations) or skipped 
because of a mutation affecting exon splicing. Mutations were then sorted into 
three groups. Mild mutations were those that were predicted to have little effect 
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on total CEP290 protein levels (in-frame deletions, missense mutations, 
truncating mutations occurring within the last exon, and splicing mutations in 
which there is evidence for high levels of normal transcript production). Moderate 
mutations were those that were predicted to significantly reduce CEP290 protein 
levels (i.e., those that resulted in a premature stop codon within, or splicing 
mutation likely to result in the skipping of, an in frame exon). Severe mutations 
were those that were predicted to act as null alleles (those that resulted in a 
premature stop codon within, or splicing mutation likely to result in the skipping 
of, an out-of-frame exon). The sorted mutations are listed in fig. S1. Mutations in 
the gene CC2D2A were sorted in an identical fashion. For our modified CEP290 
model, mutations affecting exon 6, 9, 40, or 41 were considered severe. 
Patient assessment 
 Patients were seen at the retinal degeneration clinics of the University of 
Iowa, Children’s Hospital of Philadelphia, or Center for Advanced Retinal and 
Ocular Therapeutics (University of Pennsylvania Perelman School of Medicine) 
where a family history was ascertained and the individuals received standard 
clinical examinations including assessments of visual acuity, visual fields, and 
retinal structure. The diagnosis of LCA was made by electroretinogram, and the 
diagnosis of JS was made by brain magnetic resonance imaging. Screening was 
carried out for renal disease and imaging studies were carried out, as warranted, 
for CNS (and renal) evaluations. Molecular genetic testing was carried out after 
obtaining IRB-approved consent/assent (plus parental permission). 
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Cells and cell culture 
 Primary dermal fibroblasts were isolated from patient skin punches after 
obtaining informed consent/assent, and these were grown in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin at 37°C in a humidified 5% CO2 atmosphere. Fibroblasts were 
passaged fewer than 10 times before analysis. 
CEP290 protein 
 Patient fibroblasts were washed with phosphate-buffered saline, and 
5X106 cells were lysed by incubation in 50 ml of radioimmunoprecipitation assay 
buffer (50 mM tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% 
Triton X-100) supplemented with a protease inhibitor cocktail for 30 min at 4°C. 
Cell lysates were centrifuged at 20,000g for 15 min to remove insoluble material, 
and the resulting supernatants were analyzed by SDS–polyacrylamide gel 
electrophoresis and immunoblotting using standard techniques. Blots were 
probed with antibodies against CEP290 (Abcam, ab85728) and a-tubulin 
(Abcam, ab7291) and imaged with a Typhoon 9400 instrument (GE). 
cDNA isolation 
 cDNA was isolated from patient fibroblasts using Qiagen’s RNeasy kit and 
Invitrogen’s SuperScript III First-Stand Synthesis kit following the manufacturer’s 
protocols. 
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Exon junction detection 
 Two primers plus a control forward primer were designed to amplify 
across the hypothetical exon junction of CEP290 transcripts lacking each exon 
examined, as in Fig. 4A, and used for PCR amplification of patient and control 
cDNAs. The resulting PCR products were resolved by agarose gel 
electrophoresis, imaged, gel-excised, and submitted for confirmatory Sanger 
sequencing. Primer sets for hypothetical exon junctions were as follows: 
Exons 6 
P1: GAAAATGAACTGGAGTTGGCTCTTC 
P2: CACTGTCTTCCCCTCTTCTTG 
PC: CTCTCTCTCTCTCTTGGCTCTTC 
Exons 10 
P1: CTTGATGAAATTCAGGTGCAGGAGC 
P2: CTGCTGTAGAGCCATAACATTAC 
PC: CTCTCTCTCTCGTGCAGGAGC 
Exons 41 
P1: CCAGTGGATTACAGAATGCTAAAG 
P2: CCTGATCAACAGTCATGCCAG 
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PC: CTCTCTCTCTCTCTAATGCTAAAG 
Exons 46 
P1: GATTTGCCAAGATTAAAGTCTGGTAG 
P2: GATTCATAGTGCATGCTCAACTG 
PC: CTCTCTCTCTCTCTTCTGGTAG 
TaqMan assay design and analysis 
 Custom TaqMan PCR assays were designed to specifically quantify levels 
of CEP290 transcript lacking particular exons as described in Fig. 4C. Additional 
TaqMan assays were carried out using commercially available kits for GAPDH 
and full-length CEP290 (Invitrogen). TaqMan assays were run using TaqMan 
Fast Universal Master Mix (Invitrogen), and all reactions were carried out on an 
Applied Biosystems 7500 Fast Real-Time PCR instrument. Relative 
quantification was accomplished with the DDCt method using Invitrogen’s 
CloudSuite software. Custom primer and probe sets were as follows: 
Exon 6 
Primer 1:GAAGAACAAGCAAAATTTGAAAATC 
Primer 2: CGTTTGTTCTCTCTTCTTAATTTGC 
Probe: CGAAGAGCCAACTCCAGTTCATTTTCCA 
Exon 10 
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Primer 1: ACAGTGACTACCGATCACAGTTGT, 
Primer 2: CAAAATTAGCTTCCATTCTTCTACTTTT 
Probe: AATATCTTGATGAAATTCAGGTGCAGGAGCTTAC 
Exon 41 
Primer 1: GATCAAGAGAATGATGAACTGAAAAG 
Primer 2: CTTGTTTCGAATTCCTTCTATTTTG 
Probe: AAGACTAACCAGTGGATTACAGAATGCTAAAGAAGAATT 
Exon 46 
Primer 1: GAAGGAAAACTTGAAGTTGTCATCTG 
Primer 2: TCAACTACTTTTTTCATTAAACCAATGG 
Probe: TGTCTTTCCACTTCTACCAGACTTTAATCTTGGCA 
Statistical Analysis 
 The statistical significance of the difference between three or more means 
was determined using a two-way ANOVA and Tukey’s HSD (honest significant 
difference) test. The statistical significance of the difference in predicted protein 
amounts across different phenotypes was determined using Fisher’s exact test. 
Statistical analysis was performed using GraphPad Prism software 5.0b. P 
values <0.05 were considered significant. 
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CHAPTER 3- CEP290 and the initiation of ciliogenesis 
While findings related to the functional processes of the primary cilium and 
clarification of its role in human disease have tremendously increased our 
understanding of the organelle over the past twenty years, we are still in the dark 
concerning many aspects of ciliary biology. In particular, one detail that we know 
very little about is the signal that begins the process of ciliogenesis. We know 
that with few exceptions most cells do not have a primary cilium during the cell 
cycle but form one shortly after entrance into G0 (Seeley and Nachury, 2010). 
While a pro-ciliary signal has yet to be defined, work in recent years, has begun 
to identify several inhibitors of ciliogenesis. Among these proteins, the 
centrosomal protein of 110 kDa (CP110) appears to be the main, negative 
regulator of ciliogenesis (Spektor et al., 2007). CP110 appears to act by forming 
a complex at the distal ends of the centrioles, preventing the elongation of 
microtubules from the centriolar end. In addition to other negative regulators, 
some pro-ciliary proteins, such as CEP290, are found in this complex (Tsang et 
al., 2008; Jiang et al., 2012) as well. It is thought that these proteins may be kept 
in an inactive state by the CP110 complex, preventing them from functioning in 
ciliogenesis (Tsang et al., 2008).  
While it is known that the CP110 complex must be removed for the 
elongation of the ciliary axoneme to begin, the mechanism by which this occurs 
is only beginning to be elucidated. A common speculation (Cao et al., 2009) is 
that phosphorylation of targeted ciliary proteins may be the signal that begins the 
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process of ciliogenesis. Specifically, recent results have demonstrated that the 
arrival of two kinases, tau tubulin kinase 2 (TTBK2) and microtubule-associated 
protein/ microtubule affinity regulating kinase 4 (MARK4), to the distal and sub-
distal appendages of the mother centriole, respectively, in cells shortly after 
serum starvation corresponds to the dissolution of the CP110 complex (Goetz et 
al., 2012; Kuhns et al., 2013). With the arrival of these kinases and the exit of 
CP110 from the basal bodies, ciliogenesis is observed to occur. Understanding 
the protein population at the basal bodies shortly before ciliogenesis and 
identifying the final targets of these kinases, and other kinases recently 
described, is crucial to understanding their role, if any, in the development of 
primary cilia. In this chapter, the specific role of CEP290 in this process will begin 
to be evaluated, and a commentary on the process as a whole will be provided 
as an appendix. 
CEP290 as a potential kinase target 
Given our interest in CEP290 through its association with LCA, we wanted 
to take a closer look at its role in the initiation of ciliogenesis and whether it was a 
substrate for one of the previously discussed kinases. CEP290’s position at the 
distal end of the mother centriole, where it is believed to be in a complex with and 
inhibited by CP110, make it an attractive option when considering a target for a 
pro-ciliary kinase. We chose to first investigate TTBK2 as an interacting kinase 
for a number of reasons. Included in these is the likely association of TTBK2 with 
the distal appendages, placing the kinase in very close proximity to the CP110 
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complex (Oda et al., 2014; Cajanek et al., 2014).	    In addition, CEP290 falls into 
the category of a microtubule-associated protein, a protein type that TTBK2 has 
been shown to phosphorylate (Goetz et al., 2012). Further, TTBK2’s reported 
amino acid binding motif is found in CEP290’s sequence. As such, I hypothesize 
that TTBK2 interacts with CEP290 at the base of the primary cilium and this 
interaction is crucial for the initiation of ciliogenesis (Fig. 27).	   
 
 
Figure 27: CEP290 and TTBK2. Upon an unknown signal, I hypothesize that TTBK2 
traffics to the primary cilium where it phosphorylates CEP290 during the initiation of 
ciliogenesis. 
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TTBK2 specificity 
 TTBK2 has been described as having specificity for serine/threonine 
residues with a phosphotyrosine at a +2 position (Bouskila et al., 2011). In 
analyzing the amino acid 
sequence of CEP290, two 
such potential locations 
can be found. The first 
involves serine 202 and 
tyrosine 204 in Exon 9, 
and the second involves 
serine 1380 and tyrosine 
1382 in exon 32. In 
further analyzing these 
two locations for potential 
phosphorylation using the 
NetPhos 2.0 server (Blom 
et al., 1999), the probablity of phosphorylation of serine 202 and tyrosine 204 
was determined to be likely (Fig. 28).	  Of note, the location of CEP290 serine 202 
is very close to the region of the protein (amino acid residues 237- 526) 
previously identified through a yeast two-hybrid screen to be capable of 
interacting with CP110 (Tsang et al., 2008).  
 
Figure 28: Predicted phosphorylation of CEP290. Both 
Serine 202 and Tyrosine 204 are predicted to be 
phosphorylated using the NetPhos 2.0 server. 
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TTBK2 and CEP290 
 To investigate a potential 
interaction between the two proteins, a co-
immunoprecipitation (co-IP) approach was 
utilized. Previous reports identifying 
interacting partners of TTBK2 did so 
through co-IP using the lysates of cells, 
typically human embryonic kidney (HEK) 
293 cells, which had been transfected with 
plasmids expressing tagged versions of 
both proteins of interest (Cajanek and 
Nigg, 2014; Oda et al., 2014). In an effort 
to observe potential interactions of 
CEP290 with endogenous TTBK2, I 
attempted to use a co-IP approach using 
cell lysates that had only been transfected with GFP-tagged CEP290, either 
tagged full-length protein or GFP tagged to specific portions of the protein. First, I 
tested our anti-TTBK2 antibody on cell lysates from HEK293 cells and human 
telomerase reverse transcriptase immortalized retinal pigment epithelial 1 
(hTERT-RPE1) cells. Initial western blot analysis of the lysates showed two 
bands in both lysates, with one corresponding to the expected molecular weight 
of TTBK2 (~137 kDa) and one slightly lower (Fig. 29). While at least three 
alternatively spliced isoforms of human TTBK2 are predicted according to the 
Figure 29: Western blot analysis of 
HEK293 and hTert-RPE1 cell lysates. 
Two prominent bands appear in each 
lysate, labeled with black arrows. The 
calculated molecular weight of TTBK2 
is 137.5 kDa. A band corresponding to 
the loading control alpha tubulin is 
also visible in each lane at the 
expected molecular weight of 50 kDa. 
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Universal Protein Resource (http://www.uniprot.org/uniprot/Q6IQ55) only the 
1244 amino acid isoform with a predicted molecular weight of 137 kDa has been 
characterized. The other two isoforms are predicted to result in proteins of 
approximately 129 kDa and 54 kDa. In further western blot analysis of HEK293 
cells, a third band can be observed at the approximate level of the 54 kDa 
isoform (Fig. 30). Taken together, these results indicate that the antibody 
appears capable of detecting endogenous TTBK2 in the cell lysates. In addition, 
it is possible that I am detecting shorter isoforms of the protein that have yet to 
be characterized, however, given the relative weakness in staining of even the 
expected long isoform of the protein, further work is warranted to confirm these 
are indeed the shorter TTBK2 isoforms. 
In an effort to detect an interaction between 
CEP290 and TTBK2, hTert-RPE1 cells were 
transfected with full-length GFP-tagged CEP290, GFP-
tagged CEP290 portions, or GFP alone. The location 
of these constructs on CEP290 can be found in figure 
31.	  Approximately 24 hours post transfection, the cells 
were serum starved in an effort to induce formation of 
primary cilia. As enriched levels of CEP290 and TTBK2 
are both found at the base of the cilium during the 
initiation of ciliogenesis, I hypothesized this 
Figure 30: Further 
western blot analysis 
of HEK293 cells. Three 
faint bands, labeled 
with black arrows, are 
visible in cell lysates 
stained with anti-
TTBK2 antibodies. 
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environment might aid in the detection of any potential TTBK2 and CEP290 
interaction in the cell. Following 24 hours of serum starvation, the cells were 
lysed and complexes in the lysates associated with CEP290 or portions of 
CEP290 were co-immunoprecipitated using anti-GFP antibodies. As depicted 
(Fig. 32), western blot analysis of these complexes shows a band was 
consistently observed in the IP lane (the lane in which the complex was run) of 
Figure 31: CEP290 constructs used to transfect cells. Constructs encoding either full 
length (F1- blue), N-terminal (F11- green), middle (F8- purple), or C-terminal (F12- yellow) 
were used. All constructs were GFP-tagged and human codon optimized. 
Figure 32: Co-IP of CEP290 complexes. Complexes associated with CEP290 were 
stained with anti-TTBK2 antibodies. As depicted, a potential interaction is observed 
between TTBK2 and the N-terminal (F11) portion of CEP290. 
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lysates taken from cells that had been transfected with an N-terminal portion of 
CEP290. Interestingly, the band appeared to migrate with the lower of the 
potential doublet TTBK2 bands previously described (Fig. 29). Also of note, no 
TTBK2 was ever observed in the IP lane of lysates corresponding to cells 
transfected with full length CEP290. Taken together, these results suggest a 
potential interaction between TTBK2 and the N-terminal portion of CEP290. 
To further investigate this potential interaction, a smaller N-terminal 
CEP290 portion was utilized in an attempt to narrow down the observed TTBK2 
interacting region of CEP290 (Fig. 33).	   Again, interaction between TTBK2 and 
both CEP290 N-terminal portions was analyzed by co-IP and western blot after 
the hTert-PRE1 cells were transfected, serum starved, and lysed as above. 
Surprisingly, no potential interaction between TTBK2 and the smaller CEP290 N-
terminal portion was observed (Fig. 34). The longer of the two constructs, F11, 
includes an addition 116 amino acids of CEP290 compared to the shorter N-
terminal construct F10. This finding suggests that if TTBK2 and CEP290 are 
indeed interacting at the N-terminal portion of CEP290, these 116 amino acids 
Figure 33: F10 construct. A slightly smaller N-terminal CEP290 portion (F10- orange) 
was used to define the area of CEP290 observed to interact with TTBK2. 
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are crucial for that interaction. 
Discussion 
 Fully interpreting these observations will require further investigations. 
Understanding the TTBK2 staining of the cell lysates will be necessary to 
determining the nature of the observed interaction. This is currently made difficult 
by relatively limited knowledge of endogenous TTBK2 staining. As mentioned, 
previous studies involving TTBK2 biology or investigation of TTBK2 interacting 
proteins have taken advantage of tagged constructs. If the band which 
consistently appears in the IP lane of lysates taken from cells transfected with N-
terminal CEP290 is associated with an isoform of TTBK2, the finding would be 
novel, both in terms of the interaction between the two proteins and in terms of a 
smaller isoform of TTBK2 being identified as the interacting protein. 
 Not observing an interaction between full-length CEP290 and TTBK2 after 
potentially observing a relationship between TTBK2 and a portion of CEP290’s 
Figure 34: Co-IP of complexes associated with N-terminal CEP290 constructs. 
Complexes were stained with anti-TTBK2 antibodies and analyzed by western blot. As 
depicted, an interaction is again observed in the IP lane of the F11 construct. A second, 
faint band in the lane is also observed, potentially due to background staining caused 
by the transfected construct. 
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N-terminus was unexpected. Findings made by Gerd Walz’s group at the 
University Hospital Freiburg and Anand Swaroop’s group at the National Eye 
Institute regarding an interaction between CEP290 and another ciliary protein, 
NPHP5 however, may help explain this observation (Schafer et al., 2008; Chang 
et al., 2006). In an initial study, the Swaroop group failed to record an interaction 
between full-length CEP290 and full-length NPHP5. Upon further analysis in a 
separate study, however, the Walz group observed a CEP290 fragment 
composed of amino acids 665-1288 and NPHP5 were capable of interacting.   In 
addition, the Walz group also demonstrated the N-terminus and C-terminus of 
CEP290 were capable of forming heterodimers with each other and homodimers 
with themselves. In light of these observations, the group hypothesized CEP290 
may be capable of folding on itself, potentially in an auto-inhibitory manner, and 
this folding may in some cases limit access of interacting proteins to their binding 
location on CEP290. A similar mechanism of auto-inhibition has been proposed 
for the kinesin-2 motor protein OSM-3 in C. elegans (Imanishi et al., 2006). 
Taking this into consideration, it may be that the TTBK2 binding domain on full 
length CEP290 is only available under certain circumstances, which are not 
mimicked by overexpression of the full-length protein. 
 A potential interaction between TTBK2 and CEP290 was investigated first 
for reasons previously described, however, with our current knowledge of the 
CP110 complex and associated proteins, speculations can be made regarding 
the potential interactions of other ciliary proteins that might lead to the dissolution 
of CP110 at the end of the mother centriole. A commentary on this topic is 
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covered in detail in the appendix below. As mentioned, the definitive role of 
CEP290 and TTBK2 in this process requires further investigation with many 
questions remaining. Taking into consideration the preliminary findings here, 
however, I believe those investigations would be warranted. 
 
Materials and Methods 
Cell Culture 
 HEK293 and hTert-RPE1 cells were utilized for these studies. HEK293 
cells were grown in DMEM supplemented with 10% FBS. hTert-RPE1 cells were 
grown in DMEM:F12 in a 1:1 mixture supplemented with 10% FBS. Both cell 
types were grown at 37 degrees Celsius in 5% CO2. Replacing media with low 
nutrient Opti-MEM immediately after washing cells 1X with warm PBS induced 
serum starvation.  
Transfections, co-IP, and western blot 
 Cells were transfected with GFP-tagged CEP290 constructs using 
FuGENE6 transfection reagent (Promega). Media on cells was replaced 8 hours 
post-transfection. Cell lysates were harvested 48-60 hours post transfection. 
Lysates from serum-starved cells were harvested no earlier than 24 hours post-
serum starvation and 48 hours post-transfection. Cells were lysed using Triton-X 
cell lysis buffer supplemented with protease inhibitor tablets (Roche, Complete, 
Mini, EDTA-free). A 50ul aliquot was taken of each lysate to use for western 
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analysis of GFP-expression. Remaining lysates were either used immediately for 
co-IP or snap-frozen to be used at a later date. Co-IP was carried out using anti-
GFP antibodies coupled to magnetic Dynabeads (Life Technologies Dynabeads 
antibody coupling kit, Cat. 14311D) as recommended by manufacturer. Beads 
were coupled using 6ug ab/ 1ug beads. Antibody-coupled beads and cell lysates 
were allowed to incubate 3-5 hours at 4 degrees Celsius on a spinning wheel. 
Samples were run on NuPAGE 4-12% Bis-Tris gels (Life Technologies) before 
being transferred to nitrocellulose membranes. After incubation with appropriate 
antibodies and developed using ECL2 reagent (Pierce), images of the 
membranes were taken using an Amersham Imager 600. Images were analyzed 
using ImageJ64 software. 
CEP290 plasmids 
 CEP290 plasmids encoding full-length or portions of CEP290, N-terminally 
tagged with GFP were obtained from the Bennett laboratory plasmid repository. 
Plasmids were originally generated using human codon optimized CEP290 as a 
template and cloned into Gateway vectors (pcDNA-DEST53) (Invitrogen). 
Antibodies 
 For western blot analysis, Rabbit anti-GFP antibodies from Life 
Technologies (A11122); Rabbit anti-TTBK2 antibodies from Sigma (HPA018113-
100UL); mouse anti- Alpha tubulin antibodies from Abcam (ab7291). For IP, 
Mouse anti-GPF antibodies from Roche (11814460001). HRP-conjugated anti-
mouse and anti-rabbit secondary antibodies (GE- Amersham Biosciences) were 
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used. 
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APPENDIX 
Roles of the CP110 complex and associated proteins in the initiation of 
ciliogenesis 
 
Since the identification of CP110’s inhibitory role in ciliogenesis, multiple 
interacting partners of the protein have been identified in a complex with it at the 
distal end of both centrioles before the induction of cilia formation. Included in 
this complex are both promoters of ciliogenesis and proteins described to be 
inhibitory in this process. In addition, several proteins associated with the distal 
and sub-distal appendages of the mother centriole/basal body (putting them in 
close proximity to members of the CP110 complex) have been described to be 
involved in ciliary development and maintenance. Our current understanding of 
many of these proteins as well as a set of kinases recently described to traffic to 
the base of the cilium shortly before axoneme extension will be discussed below. 
In addition, speculations regarding potential interactions yet to be observed 
between some of these proteins will also be covered. 
 
CP110 and associated proteins 
Inhibitory proteins of mention 
CP110 
 As mentioned above, CP110 plays a prominent role in the inhibition of 
ciliogenesis. The protein was first characterized in a screen for substrates of 
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cyclin-dependent kinases (CDKs) carried out by Brian Dynlacht’s laboratory of 
New York University’s School of Medicine (Chen et al., 2002). In addition to 
successfully identifying the protein as a CDK substrate, the group also observed 
it as a component of the centrosome. In investigating cellular levels of CP110, 
they found levels of the protein to peak in the entrance of cells to S phase from 
G1 phase. Meanwhile, minimal levels of CP110 were observed in lysates of 
quiescent cells (Chen et al., 2002). In addition, RNAi knockdown of the protein 
led to multiple examples of genomic instability, resulting in the group concluding 
CP110 was likely playing a role in the cell cycle through its interaction with the 
centrosomes. This conclusion was later confirmed when Erich Nigg’s group of 
the Max-Planch Institute observed CP110 to aid in early centriole biogenesis 
(Kleylein-Sohn et al., 2007).  
Around the same time that the cell cycle role for CP110 was being 
described by Nigg’s group, the Dynlacht laboratory published findings 
characterizing a ciliary role for the protein. In this paper, the group observed that 
CP110 acts to suppress ciliogenesis from the basal body, potentially by forming a 
cap at the distal end of the centrioles to prevent axoneme extension. It was found 
that this cap must be removed from the mother centriole for ciliogenesis to occur. 
Supporting this, it was observed that knockdown of CP110 leads to inappropriate 
formation of cilia-like structures from at least one but sometimes both centrioles 
(Spektor et al., 2007). These structures were observed to positively stain for 
acetylated tubulin and polycystin-2, markers of ciliogenesis (Spektor et al., 2007; 
Cai et al., 1999). In contrast, when cells are transfected with plasmids expressing 
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CP110, the percentage of cells that form primary cilia is greatly reduced despite 
pro-ciliary environments (Spektor et al., 2007) again supporting an inhibitory role 
for CP110 at the basal bodies (Fig 35).	   Taken together, CP110 appears to have 
at least two distinct roles, one functioning early in the production of centrioles at 
the centrosome and 
another in inhibiting the 
process of ciliogenesis 
at the basal body. 
Cep97 
 In order to further 
discuss the role of 
CP110 at the primary 
cilium, centrosomal 
protein 97 kDa (Cep97) should be introduced. Leading up to the observation of 
its ciliary role, the Dynlacht group also purified complexes associated with 
CP110, identifying Cep97. Initial experiments undertaken to define the 
relationship of these two proteins demonstrated that Cep97 is required for 
localization of CP110 to the centrosomes and the depletion of Cep97 leads to 
CP110 instability as well as a significant reduction of CP110 cellular amounts. 
Interestingly, while CP110 depletion also led to a loss of Cep97 at the 
centrosomes, no effect was observed on cellular Cep97 amounts. This suggests 
that both proteins play a role in the other’s recruitment to the centrosomes but 
Figure 35: CP110, Cep97 and cilia formation. 
Overexpression of CP110, Cep97, or both reduces 
primary cilia formation in NIH 3T3 cells. *Figure 
adapted from Spektor et al., 2007 
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only Cep97 functions in the stabilization of CP110 (Spektor et al., 2007). Similar 
to CP110 depletion, siRNA knockdown of Cep97 also leads to the appearance of 
cilia-like structures. Overexpression of Cep97 did not lead to as severe a 
reduction of cells forming primary cilia compared to that of CP110, however, 
suggesting the definitive role of ciliary inhibition may be due to CP110. 
Cep76 
 Another inhibitory member of the CP110 complex is centrosomal protein 
76 kDa (Cep76) (Tsang et al., 2009). In addition to interacting with CP110, 
Cep76 also appears to be associated with Cep97 at the centrosome. Relatively 
little is known about this protein other than it seems to function in inhibiting 
reduplication of the centrioles during S phase, perhaps by inhibiting pro-centriolar 
proteins such as CP110. While CP110 appears to have both a cell cycle and 
ciliary role, a function of Cep76 at the primary cilium has yet to be described. 
Kif24 
 A rather unique member of the ciliary CP110 complex and one of the more 
recently described is Kinesin family member 24 (Kif24) (Kobayashi et al., 2011). 
As its name implies, Kif24 is a member of the kinesin family (specifically kinesis-
13) of M-kinesin molecular motor proteins (Ems-McClung and Walczak, 2010). 
While N-kinesins and C-kinesins are involved in moving cargo along 
microtubules in the cell, M-kinesins are involved in depolymerizing microtubules 
(Shipley et al., 2004). Kif24 has been shown to not only interact with both CP110 
and Cep97 at the distal end of the mother centriole but also phenocopy both of 
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these proteins in that knockdown of Kif24 leads to the formation of primary cilia in 
cycling cells (Kobayashi et al., 2011). Hinting at its precise role in the inhibition of 
ciliogenesis, Kif24 was found to specifically depolymerize centriolar microtubules 
but not cytoplasmic microtubules. This suggests a model by which Kif24 interacts 
with CP110/Cep97 at the distal end of the mother centriole and functions to 
counteract any attempt of axoneme extension by depolymerizing microtubule 
extension from the basal body until the complex is removed. 
 
Pro-ciliary proteins of mention 
CEP290 
The association of CEP290, a promoter of ciliogenesis, with the ciliary 
CP110 complex was an important finding and one that introduced a new 
mechanism by which CP110 may be inhibiting ciliogenesis. Again, the Dynlacht 
group was behind the observation, demonstrating that CEP290 and CP110 are 
capable of interacting and that the interaction could be mapped to the N-terminus 
of CEP290. As mentioned previously, CEP290 is found at the distal ends of the 
mother and daughter centrioles, both during the cell cycle and G0 while CP110 is 
observed to leave the end of the mother centriole during G0 but maintain its 
association and co-localization with CEP290 at the end of the daughter centriole 
(Spektor et al., 2007; Tsang et al., 2008). In addition, knockdown of CEP290 
mRNA by siRNA leads to a suppression of ciliogenesis, a phenotype that is in 
direct contrast to the pro-ciliary effect of knocking down CP110 levels. Of note, 
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however, knockdown of CEP290 mRNA had no effect on the cell cycle, 
suggesting only a ciliary role for the protein. Furthermore, depletion of CEP290 
has been shown to result in 
altered organization of PCM-
1, a pericentriolar matrix 
protein known to be required 
for ciliogenesis (Kim et al., 
2008), and the loss of 
Rab8a, a regulator of vesicle 
trafficking (Zerial and 
McBride, 2001) that 
functions in generation of the 
ciliary membrane, in the 
primary cilium (Kim et al., 
2008).  
As ciliogenesis is not observed to occur until after CP110 leaves the end 
of the mother centriole, the Dynlacht group hypothesized that CP110 may be 
interacting in an inhibitory way on CEP290, suppressing its ability to function in 
ciliogenesis. To test this, the group repeated their initial experiment in which they 
had demonstrated that overexpression of CP110 in cells led to almost complete 
suppression of primary cilia.  Instead of overexpressing wild-type CP110, 
however, the group transfected the cells with a version of CP110 incapable of 
binding CEP290. In doing so, the suppression of primary cilia was almost 
Figure 36: Ectopic expression of CP110 plasmids in 
NIH 3T3 cells.  As depicted above, expression of 
CP110 plasmids result in a decrease in primary cilia. 
This phenotype is suppressed when the transfected 
CP110 plasmid is missing a region described as 
crucial for its interaction with CEP290. *Figure 
adapted from Tsang et al., 2008 
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completely reversed, suggesting the inhibitory nature of CP110 before 
ciliogenesis is dependent on its ability to interact with CEP290 (Fig. 36)(Tsang et 
al., 2008).	  	  
Talpid3 
 Talpid3 was first recognized as being essential for the formation of primary 
cilia by Cheryll Tickle’s group at the University of Bath (Yin et al., 2009). Another 
promoter of ciliogenesis and a member of the ciliary CP110 complex, the protein 
appears to localize with the centrosome during the cell cycle and the basal body 
of the primary cilium in quiescence (Kobayashi et al., 2014). Specifically, Talpid3 
is observed at the distal ends of both the mother and daughter centrioles close to 
the distal appendages during ciliogenesis. Knockdown of Talpid3 phenocopies 
that of CEP290 in that depletion leads to suppression of primary cilia formation, 
altered organization of PCM1 granules, and depletion of Rab8a in the primary 
cilium- all while having no effect on the cell cycle. In regards to Talpid3 function, 
intricate transition electron microscopy (TEM) analysis of retinal pigment 
epithelial (RPE) cells at the initiation of ciliogenesis in Talpid3-depleted and 
control cells seems to indicate that Talpid3 acts to help capture primary ciliary 
vesicles on the distal appendage of the mother centriole shortly after the cell 
receives the signal to begin ciliogenesis (Kobayahi et al., 2014). These vesicles 
go on to mature into ciliary vesicles at the top of the mother centiole and 
eventually form the ciliary membrane, Sorokin, 1962). Together, these results 
suggest Talpid3 function is critical for early ciliary vesicle capture and ciliary 
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membrane maturation. 
Cep104 
 Another pro-cliliary member of the CP110 complex is Cep104. In addition 
to its previously described presence at the centrioles (Jakobsen et al., 2011), the 
Akhmanova laboratory at Utrecht University first characterized the ciliary 
involvement of the protein after it was identified in a screen for microtubule plus 
end trafficking proteins (+TIPs) (Jiang et al., 2012). +TIPS are typically found at 
the growing ends of microtubules where they are observed to play various roles, 
including recruiting other factors to the microtubule ends and aiding in their 
connection to other cellular structures. The group showed Cep104 
immunoprecipitates with both CP110 and Cep97 and that Cep104 and CP110 
co-localize to the distal ends of the centrioles during interphase. Interestingly, the 
two also co-localize after the initiation with ciliogenesis, with both found at the tip 
of the daughter centriole but neither at the distal end of new basal body. As 
CP110 and Cep97 are known in inhibitors of ciliogenesis, these findings would 
seem to indicate a similar role for Cep104. However, depletion of Cep104 
actually leads to a reduction in the ability of cells for form primary cilia with no 
other defects observed in cell cycle or centriole length (Jiang et al., 2012). Taken 
together, a role of Cep104 could be hypothesized where it helps to stabilize the 
CP110 complex during the cell cycle, but its presence is necessary for the 
process of ciliogenesis to occur. 
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Distal Appendage Proteins  
Cep164 
 Cep164 was first associated with the centrosome in 2003, having been 
identified in a mass-spectrometry-based analysis of human centrosomes 
(Andersen et al., 2003). Shortly after, the protein’s localization was narrowed 
down to the distal appendages of the mother centriole. In addition, Cep164 was 
determined to be required for ciliogenesis with cilia formation suppressed in 
Cep164 depleted cells. (Graser et al., 2007). Of note, the location of Cep164 at 
the distal appendages puts it in close proximity with the CP110 complex 
members at the end of the mother centriole including Talpid3 and CEP290 
(Spektor et al., 2007; Kobayashi et al., 2014)(See model below). 
 A very recent finding by two independent laboratories describes Cep164 
as a recruiter of Tau Tubulin Kinase 2 (TTBK2) to the basal bodies before the 
initiation of ciliogenesis. As will be discussed later in further detail, TTBK2 has 
been described to be crucial for the initiation of ciliogenesis, and its arrival at the 
basal body coincides with the removal of CP110 (Goetz et al., 2012). In addition, 
the recruitment of TTBK2 by Cep164 was shown to depend on a N-terminal WW 
domain on Cep164.  
 In light of the observation of Cep164 at the distal appendages and its 
interaction with TTBK2, Erich Nigg’s group at the University of Basel set up a 
clever experiment to determine if one function of Cep164 was to recruit TTBK2 to 
the basal body, specifically the distal appendages of the mother centriole. In this 
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experiment, the group fused the C-terminal portion of Cep164, the portion known 
for targeting Cep164 to the distal appendages, to TTBK2. They then transfected 
this construct into Cep164-depleted cells and observed a rescue of ciliogenesis, 
suggesting Cep164 aids in the recruitment of TTBK2 to the distal appendages 
and this recruitment plays a role in the formation of the primary cilium (Cajanek 
and Nigg, 2014). 
Cep123 
 Cep123, also referred to as Cep89 is another distal appendage protein. 
Like Cep164, Cep123 is required for ciliogenesis and the C-terminal portion of 
the protein appears to target it to the distal appendages (Sillibourne et al., 2013). 
Interestingly, siRNA-mediated depletion of Cep123 after the induction of 
ciliogenesis had little effect on primary cilia, suggesting the protein is only 
involved in initiation of ciliogenesis and not maintenance. 
 The role of Cep123 in the initiation of ciliogenesis was investigated by the 
Bomens laboratory at the Institut Curie. In doing so, the group observed that 
while distal appendages still formed in Cep123-depleted cells, the docking of 
ciliary vesicles to the distal end of the mother centriole was perturbed, suggesting 
a very early role for the protein in ciliary initiation (Sillibourne et al., 2013). 
 Interestingly, Cep123 was also found to co-immunoprecipitate with PCM-1 
and CEP290, likely at the centriolar satellites where CEP290 can be found in 
addition to its transition zone localization (Kim et al., 2008; Sillibourne et al., 
2013). 
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Cep83 
 Another member of the DAPs is Cep83. Only recently characterized by the 
Tsou group at Memorial Sloan-Kettering, Cep83 appears to be required for 
recruitment of both Cep123 as well as Cep164 to the DAPs as depletion of 
Cep83 leads to their loss at the appendages. Depletion of the other DAP proteins 
has no effect on Cep83’s DAP localization, however, suggesting Cep83 forms 
the connection required for the other proteins’ association (Tanos et al., 2013). In 
regards to this role, it is no surprise that Cep83 is also required for the initiation of 
ciliogenesis, and as DAPs are involved in docking the mother centriole to the 
cellular membrane, mother centrioles in Cep83 depleted cells fail to dock to the 
cellular membrane (Tanos et al., 2013) 
Kinases  
TTBK2 
Several groups have recently placed Tau Tubulin Kinase 2 (TTBK2), a 
serine/threonine kinase capable of phosphorylating microtubule associated 
proteins, at the base of the cilium during the initiation of ciliogenesis (Goetz et al., 
2012; Cajanek and Nigg, 2014; Oda et al., 2014). TTBK2, in addition to TTBK1, 
is a member of the TTBK family of the casein kinase 1 (CK1) group (Ikezu and 
Ikezu, 2014). While the kinase domains of these two proteins are very similar, 
their sequences outside of these domains differ substantially. TTBK1 appears to 
be exclusively expressed in the CNS (Sato et al., 2006) where it is found to be 
upregulated in the brains of human Alzheimer disease (AD) patients (Sato et al., 
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2008). TTBK2 appears to be ubiquitously expressed throughout the body with 
mutations in the protein associated with Spinocerebellar ataxia type 11 (SCA11) 
(Houlden et al., 2007). In light of its expression throughout the body and its 
recent implication in ciliary health, however, it is likely that mutations in this 
protein will soon be linked to several other conditions. 
The largest TTBK2 isoform is composed of 1244 amino acids. Most of the 
protein (~960 amino acids) is dedicated to a portion C-terminal to the kinase 
domain, which appears to be involved in localization (Goetz et al., 2012)(Fig.37). 
While this region is known to contain a SxIP motif, which, as mentioned 
previously, can be found on microtubule plus-end trafficking proteins, (Jiang et 
al., 2012) the rest of the C-terminal region remains mostly uncharacterized. The 
kinase domain of TTBK2, which appears to be necessary for the induction of 
ciliogenesis (Goetz et al., 2012), has been shown to be capable of 
phosphorylating serines 208 and 210 of the tau protein and is described to have 
specificity for substrates with a phosphotyrosine at a +2 position of the 
phosphorylation site.	   
 
Figure 37: Illustration of TTBK2. The C-terminal tail of TTBK2 makes up most of the 
protein. The kinase domain, however, has been shown to be crucial for the function of 
the protein in ciliogenesis. 
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As mentioned previously, TTBK2 was recently found to localize to the 
base of the primary cilium during the initiation of ciliogenesis. This observation 
was first made by Kathryn Anderson’s laboratory at the Sloan-Kettering Institute 
using a screen to identify mutations 
leading to defects in neural 
patterning of mouse embryos 
(Goetz et al., 2012).  Embryos with 
null Ttbk2 mutations were identified 
after arresting in mid-gestation, a 
hallmark phenotype of Shh defects 
(Huangfu et al., 2003). Altered Shh 
signaling in the embryos was 
confirmed by the absence of ventral neural cell types, specifically Shh-expressing 
floor plate cells (Fig. 38).	    As the Anderson group was the first to link Shh 
signaling to Ift-88 and ciliary health, the group examined the primary cilia of the 
neural tubes in the mutant embryos, finding a complete absence of cilia on the 
null Ttbk2 cells (Fig. 39).	    Interestingly, however, mature basal bodies with 
formed distal appendages could be detected in the cells near the membrane, 
suggesting the cell was primed to form a cilium but was restricted from doing so 
and that Ttbk2 may be involved in this process. Moreover, staining for CP110 
showed the protein to remain in place at the distal end of the mother centriole in 
serum starved, Ttbk2 null mice, narrowing in on a potential function for Ttbk2 at 
the primary cilium. Further experiments with GFP-tagged Ttbk2 constructs 
Figure 38: Absence of Shh expression in 
Ttbk2 null mice. Shh is depicted as purple 
staining in the floor plate cells of wild-type 
animals (C). No Shh is visible in the floor 
plates of Ttbk2 null mice. *Figure adapted 
from Goetz et al., 2012. 
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showed that the protein traffics to the basal bodies 
upon serum starvation, the C-terminal portion of the 
protein is required for this trafficking, and a functional 
kinase domain is necessary to rescue CP110 removal 
and initiation of ciliogenesis in Ttbk2 null cells (Goetz 
et al., 2012). 
While the Anderson laboratory did not 
described a target for TTBK2 at the basal body, 
subsequent work has shown that the protein is likely 
recruited to the basal body through interactions with 
Cep164, which it has been shown to bind to and be 
capable of phosphorylating (Cajanek and Nigg et al., 
2014; Oda et al., 2014). Interestingly, an in vitro kinase assay involving TTBK2 
and Cep97 showed that TTBK2 was also capable of phosphorylating Cep97 as 
well, but the relevance of this potential interaction was not described in vivo (Oda 
et al, 2014). Regarding TTBK2 and Cep164, their interaction was determined to 
be crucial for ciliogenesis to occur (Oda et al., 2014). Interestingly, further work 
by the Nigg laboratory showed that overexpression of TTBK2 led to recruitment 
of Cep164, Cep83, and Cep123 to the daughter centrioles. This observation, that 
TTBK2 may be capable of recruiting DAPs to the centrioles which then in turn 
recruit more TTBK2, suggests a potential positive feedback loop for the protein, 
involving TTBK2 both in the maturation of the basal body and the final step if 
CP110 removal (Cajanek and Nigg, 2014). 
Figure 39: Cells of the 
neural tube lack cilia in 
Ttbk2 null mice. Cila 
extend normally in 
cells of wild-type mice 
(G) but do not in cells 
of Ttbk2 null mice (H). 
Arrows point to distal 
appendages.*Figure 
adapted from Goetz et 
al., 2012. 
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MARK4 
 Another kinase observed to locate to the basal body before the initiation of 
ciliogenesis is Microtubule-associated Proteins/Microtubule Affinity-regulating 
Kinase 4 (MARK4) (Kuhns et al., 2013). First identified by the Furukawa 
laboratory at the University of Tokyo due to its elevated expression in 
hepatocellular carcinogenesis (Kato et al., 2001), the centrosomal association of 
MARK4 was characterized shortly thereafter (Trinczek et al., 2004). 
 The sub-distal appendage protein (SAP), ODF2, was recently identified as 
an interacting partner of MARK4 at the basal body (Kuhns et al., 2013). As the 
name implies, sub-distal appendages are found directly below the distal 
appendages on the basal body. Here, the SAPs appear to be involved in the 
anchoring of microtubules and aiding in vesicle docking (CC2D2A, saps).  While 
Cep164 is described as the major component of the DAPs, SAPs appear to be 
largely composed of ODF2 (Tateishi et al., 2013). The Pereira Laboratory of the 
German Cancer Research Center was the first to report the interaction of MARK4 
and ODF2. In very similar findings to the relationship of TTBK2, Cep164, and the 
DAPs, the Pereira group reported that MARK4 and ODF2 interact in vivo, 
MARK4 is capable of phosphorylating ODF2 in vitro, and that a functional 
MARK4 kinase domain is important for ciliogenesis.  In addition, MARK4 appears 
to be at least partially responsible for ODF2 localization to the centrosome as 
mislocalization of ODF2 was observed in MARK4 depleted cells and 
overexpression of MARK4 resulted in enhanced centrosomal association of 
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ODF2. Interestingly, depletion of either MARK4 or ODF2 resulted in inhibition of 
axoneme extension but not early vesicle docking to the end of the mother 
centriole. In addition, overexpression of ODF2 in MARK4 depleted cells rescued 
the reduction of cilia observed after the loss of MARK4 (Kuhns et al., 2013). 
Taken together, the findings by the Pereira group also seem to highlight a 
positive feedback role of the MARK4/ODF2 interaction where ODF2 is present at 
the SAPs before axoneme extension but not necessarily aiding in early vesicle 
recruitment. Upon an unknown signal, however, and after docking of the ciliary 
vesicle to the end of the mother centriole, MARK4 might be targeted to basal 
body where it interacts with ODF2, and likely other targets, stabilizing the SAPs 
and leading to the recruitment of more ODF2. This increased concentration of 
ODF2 at the SAPs may allow the nascent cilium to deal with the larger amount of 
incoming vesicles throughout the process of ciliogenesis, leading to maturation of 
the structure (Kuhns et al., 2013).  
Nek kinases 
 The Nek kinases are a group of relatively uncharacterized mammalian 
kinases with closely related catalytic domain sequence homology (Holland et al., 
2002). Currently, eleven Nek family members (Nek 1-11) have been described, 
ranging in proposed function from cell cycle control and DNA damage response 
to cytoskeletal organization (Fry et al., 2012). Of note, ciliary roles have been 
proposed for Nek1, Nek8, and most recently, Nek4. Nek1 and Nek 8 were first 
linked to the primary cilium through their association with the polycystic kidney 
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disease phenotype of the kat mouse and jck mouse, respectively (Upadhya et al., 
2000; Liu et al., 2002).  
While the mechanisms behind the phenotypes observed in both mouse 
models requires further investigation, recent work involving Nek1 describes a 
reduction of cilia observed in cultures of embryonic fibroblasts isolated from a kat 
mouse strain when compared to wild-type cultures (Ohad et al., 2008). In 
addition, a yeast two-hybrid screen of human fetal brain cDNA using the C-
terminal regulatory domain of human NEK1 as bait identified Kif3a, a subunit of 
kinesin-II, as a likely interacting partner (Surpili et al., 2003). As described 
previously, anterograde intraflagellar transport is dependent on Kinesin-II (Cole 
et al., 1998), and knock-outs of Kif3a result in loss of cilia (Zhao et al., 2012).  
The observation that NEK1 and Kif3A could be interacting partners is important 
given the crucial role of Kif3A in the initiation and maintenance of ciliogenesis. If 
Kif3A is indeed a substrate of NEK1, determining the timing of this interaction, as 
well as potentially others involving NEK1, with the onset of ciliogenesis, will be 
necessary to determine its role at the primary cilium. 
Ronald Roepman’s group at the Radboud University Nijmegen Medical 
Center is responsible for the recent observation of NEK4 at the primary cilium. In 
looking for potential binding partners of retinitis pigmentosa GTPase regulator-
interacting protein 1 (RPGRIP1) and RPGRIP1-like protein (RPGRIP1L), two 
proteins in which mutations lead to a spectrum of phenotypes from LCA to MKS, 
the group identified NEK4 as a member of complexes formed by both proteins 
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(Coene et al., 2011). Both RPGRIP1 and RPGRIP1L can be observed at the 
basal bodies of cilia with RPGRIP1 also observed in the connecting cilium of 
mouse photoreceptors (Zhao et al., 2003). NEK4 staining showed similar 
localization of the protein, appearing at basal bodies in human retinal pigment 
epithelial (hTert-RPE) cells and closely related to the connecting cilium of rat 
photoreceptors (Coene et al., 2011). Specifically, the group showed that NEK4 
appears to locate to the ciliary rootlet, extensions of the basal body that project 
into the cell and are thought to be associated with ciliary stability (Coene et al., 
2011, Yang et al., 2005), in several ciliated tissues. Functionally, depletion of 
NEK4 through siRNA, led to a decrease in ciliated cells without any observed 
effects on the cell cycle. The group did not, however, find any evidence that 
RPGRIP1 or RPGRIP1L are targets of NEK4 phosphorylation, suggesting the 
proteins may be acting as a scaffold to bring NEK4 and potentially its substrate 
or substrates to the base of the cilium. 
CP110 complex and associated proteins, interactions and predictions 
The nature of the environment around the CP110 complex at the end of 
the mother centriole appears both dynamic and fragile, with multiple kinases 
trafficking to it before cilium formation begins and the integrity of the entire 
complex itself dependent on the individual integrity of most of its members. An 
interesting finding related to this environment is the suggested positive feedback 
relationships between TTBK2 and MARK4 and the DAPs and SAPs, 
respectively. These interactions, discussed further by Tsang and Dynlacht, 
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provide a logical mechanism by which levels of both kinases and structural 
proteins are effectively recruited to and maintained at the cilium to ensure 
formation and maintenance (Tsang and Dynlacht, 2013). However, like the 
observation of NEK4 at the ciliary rootlets, they do not necessarily implicate a 
target substrate which, when phosphorylated, clearly leads to the dissolution of 
the CP110 complex and the initiation of ciliogenesis. In fact, outside of TTBK2’s 
ability to phosphorylate Cep97 in vitro and NEK1’s potential interaction with 
Kif3a, the roles of the kinases described above so far appear to be mostly 
structural in nature. That being said, however, it could be that interactions 
between the kinases and members of the CP110 complex (interactions that 
might lead to demise of the complex) are simply more difficult to observe in 
contrast to the interaction of the kinases with DAPs and SAPs, which lead to 
stabilization of the structures and amplification of the readout through further 
recruitment of each protein.  If this is the case (which I believe it to be), 
investigations into further interacting partners of the kinases and specifically 
interactions with members of the CP110 complex should be made. While the 
CP110 complex and associated proteins are just a subset of the ciliary proteome, 
the observations described above of each protein’s individual role in the initiation 
of ciliogenesis reinforce the importance of their presence. Using the information 
obtained from these data provides a map of known protein interactions and 
allows the possibility to speculate the potential of some interactions yet to be 
observed (See model below).  
Outside of CEP290, a protein whose close relationship with CP110 is well 
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Model of CP110 complex and associated proteins: CP110 complex composed of CP110, 
Cep97, Cep104, Cep76, CEP290, Kif24, and Talpid3 is observed on the distal end of 
each centriole (dark green cylinders). In addition, Kif3A, a Kinesin-II subunit, may be 
found in close proximity. Distal appendages of the mother centiole (blue triangles near 
distal end of top centriole) appear to be composed of several proteins, including 
CEP164, Cep123, and Cep83, with Cep83. ODF2 can be found at the sub-distal 
appendages (orange triangles directly below the distal appendages of the mother 
centriole). RPGRIP1 and RPGRIP1L are associated with the ciliary rootlets (depicted as 
brown bars below the mother centriole). Kinases (represented as diamond shapes) are 
located in the model near their described interacting partners with the exception of 
NEK1 and NEK8. NEK1 potentially interacts with Kif3A. No interacting partner of NEK8 
at the cilium has been described. 
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documented, and the potential interactions of TTBK/Cep97 and NEK1/Kif3a just 
mentioned, Cep104 may be the best substrate candidate for further investigation 
into a kinase driven model for the initiation of ciliogenesis.  As previously 
described, Cep104 appears to be a prociliary factor as its deletion leads to a loss 
of cilia formation. Interestingly, however, the protein is found to co-localize with 
CP110 both before ciliogenesis and after, when it is observed to leave the 
centriolar end along with CP110. As the protein is required for formation but 
leaves shortly after and is a known interacting protein of both CP110 and Cep97, 
perhaps Cep104 serves to recruit one of the kinases to its final destination at the 
end of the centriole where either Cep104 or another member of the complex is 
then phosphorylated, leading to the dissolution of the CP110 complex. 
How the CP110 complex and associated proteins described here, as well 
as those yet to be identified, interact will continue to be clarified as more focus is 
placed on ciliary biology. Determining the definitive signal that leads to the 
formation of the cilium, whether it is kinase driven or not, will be a seminal finding 
in the field. Given the close relationship of cilia formation and the cell cycle, 
identification of such a signal would likely be welcomed by basic and applied 
scientist, alike. 
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CHAPTER 4- Remaining questions and future directions 
The field of ciliary biology is currently in an interesting and exciting period. 
In one sense, the description of cilia and flagella as the first organelles to be 
observed makes the field the oldest of cellular and molecular biology. On the 
other hand, recognition of the cilia’s cellular role has only recently expanded from 
an organelle solely involved in locomotion to one of exceptional complexity and 
variability. How the work presented here plays a part in the field as a whole will 
continue to be evaluated as investigations into the biology of the cilium, from 
formation and maintenance to its role in disease, continue to expand our 
knowledge of the organelle. 
 Regarding the model of CEP290-associated disease pathogenesis 
presented, several questions remain. One of these is the likelihood of this model 
applying to other genes associated with a spectrum of diseases. While we lack 
complete understanding of CEP290 and CC2D2A’s cellular function, both 
proteins appear to be structural in nature. The model assigns degrees of severity 
to the different types of mutations based on the hypothesized effect of each 
mutation on levels of functional protein of interest, with missense mutations in the 
least severe category. As missense mutations have the potential to severely 
affect enzymes, it is likely that proteins such as these may not readily fit into the 
model as currently described. As such, it is probable that potential future disease 
genes of which this model applies will also encode structural proteins. Identifying 
these genes requires, at the very least, a defined patient population with readily 
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accessible genotype and phenotype information. This is currently a limiting factor 
in finding new candidate genes, specifically ciliary genes, as most diseases 
associated with ciliary health are very severe due to the role of cilia in 
development. As developmental defects are often embryonic lethal, large, 
defined populations of patients with mutations in ciliary genes are quite rare. 
 Another question regarding observed pathogenesis in CEP290 cases is 
why some tissues appear to be rescued from disease and others, such as the 
eye, appear to always be affected. One hypothesis regarding this is that the 
levels of alternative splicing may be different for each tissue type. This 
hypothesis would suggest higher amounts of alternative splicing in the cells of 
tissue that appear more resistant to disease, such as those of the neural floor 
plate. In theory, the increased alternative splicing would provide these cells with 
more near full-length protein with which to function. In comparison, it would 
suggest cell types in tissue more susceptible to disease, such as the retina, have 
relatively less alternative splicing, resulting in smaller amounts of exon-skipped 
isoforms and, as a result, more observable disease. Further investigations using 
qPCR of cDNA isolated from each tissue of interest would shed light on this 
hypothesis. In addition, the use of induced pluripotent stem cells (iPSCs), which 
could be differentiated into different cell type precursors, might be a useful way to 
investigate this possibility. A difference in splicing between the tissue types 
playing a role in presentation of disease is particularly attractive in terms of 
potential therapeutic approaches. Isolating a specific splicing factor that could be 
used to increase splicing in cells or isolating a drug capable of increasing the 
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amount of alternative splicing might prove to alleviate symptoms specific to those 
cell types. While the affect of increasing alternative splicing on the health of those 
tissues is unknown, the approach would be rather straightforward if you were 
able to treat the tissue early enough. 
 Another hypothesis is that the necessity of absolute ciliary health may be 
different for each tissue. That is, the normal role of the cilia in each tissue may 
dictate how well that tissue deals with mutations that affect the integrity of the 
organelle. As described earlier Ptch and Smo, two players in Shh signaling, are 
observed to locate to the cilium, and their function and location is necessary for 
successful hedgehog signaling. In this sense, the cilium appears to be involved in 
providing a location of enriched Ptch and Smo for the initial stages of hedgehog 
signaling which is crucial for normal development. In a photoreceptor, however, 
the cilium serves as a structural component of the cell, physically linking the inner 
segment to the outer segment, and, in doing so, anchoring the outer segment 
while providing a connection through which it receives newly synthesized 
proteins and removes waste. As the role of the cilium can vary in each tissue 
type, perhaps tissues that depend less on the structural integrity of the cilium are 
more resistant to disease. As an example, we can return to the oak ridge 
polycystic kidney orpk mouse in which two different mutations have been 
described. One mutation leads to a complete knockout of the Ift88 allele, which 
encodes an IFT protein known to be necessary for cilia formation. The resulting 
phenotype is a failure of the embryo to develop past mid-gestation and a 
complete lack of cilia on ventral node cells. The other mutation, however, is 
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hypomorphic, resulting in the production of minimal amounts of Ift88 and a 
rescue from the embryonic lethal phenotype of the null mice. The hypomorphic 
mice do experience severe kidney disease, however, eventually leading to death 
within a few weeks. Closer analysis of the kidney tubule cells in these mice show 
they are capable of forming primary cilia, however, the cilia are much shorter 
than those observed in wild-type mice. Of note, retinal degeneration is also 
observed in these mice. While further investigations regarding functional Shh 
pathways in both forms of this model are needed (specifically whether the ventral 
node cells of the hypomorphic mice also exhibit shortened primary cilia), it is 
enticing to hypothesize the hypomorphic embryos are rescued from the 
embryonic lethal phenotype due to minimal but present activity of the Shh 
pathway. That is, while the primary cilia of hypomorphic mice are much smaller 
and this leads to defects in kidney and retinal function, two aspects of ciliary 
function highly dependent on structural integrity of the cilium, they may still be 
capable of providing the enriched Smo and Ptch levels necessary for Shh activity 
and embryonic development.   
 Finally, another question to be explored regarding this model is its clinical 
significance related to CEP290 disease. While there is currently no cure for 
CEP290-assoicated disease, palliative treatment is available. As the symptoms 
associated with CEP290 disease progress in severity as the patient ages, 
understanding the likely severity of an individual’s eventual disease before 
symptoms worsen, or in some cases appear, would be valuable knowledge for 
clinicians and patients, alike, allowing the monitoring of a patient’s disease to be 
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adjusted accordingly overtime. 
 In general, we are still a long way from understanding the relationship of 
the CP110 complex and associated proteins in the initiation and maintenance of 
ciliogenesis explored in the second part of my work. Understanding the roles of 
CEP290 and TTBK2 in these processes will require further investigations. 
However, in addition to increasing our basic understanding of ciliary biology, 
continuing to map the interactions of all ciliary proteins could lead to the 
identification of new disease genes and potential therapeutic approaches for 
patients suffering from ciliopathies. Currently, gene augmentation strategies 
involving many of the known ciliary genes are prohibited by the limited cargo 
capacity of AAV vectors. In this regard, understanding the roles of ciliary 
proteins, especially those believed to be involved in the recruitment of others, is 
especially important. In analyzing the relationship of CEP164 and TTBK2 (as 
discussed earlier), the Nigg group used an interesting approach to rescue 
ciliogenesis in CEP164 depleted cells by transfecting in constructs composed of 
TTBK2 fused to the distal appendage-targeting portion of CEP164. While the 
group used this approach to demonstrate CEP164 was involved in TTBK2 
recruitment to the base of the cilium, a similar therapeutic approach could 
theoretically be used to treat disease associated with mutations in proteins 
responsible for kinase recruitment. The coding sequence of a theoretical fusion 
protein composed of, at minimum, the catalytic domain of a kinase or another 
small ciliary protein and a targeting sequence should fit into an AAV vector. Such 
a construct may be capable of rescuing disease in a patient with specific 
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mutations in a large recruiting protein. 
As cilium formation appears to be a highly regulated step in the cell cycle, 
identification of a protein that functions as the definitive step in the initiation of 
ciliogenesis could theoretically have anti-cancer implications. In such a scenario, 
targeting cancerous cells with a strong, pro-ciliary factor might lead to 
sequestration of the centrosome and its conversion to the basal body and an 
inhibition of cellular replication. 
 Discussing any novel treatment approach, however, always comes with 
additional concerns. In terms of the use of a theoretical fusion protein, application 
of such methods would likely be confined to the retinal phenotypes associated 
with cilia disease due to immunologic concerns. While the retina is only one of 
the many tissues affected by ciliary disease, it may be the only practical tissue to 
target when taking into consideration the point at which cells would have to be 
treated in order to prevent irreversible disease. It is very unlikely, even without 
taking the political and legal implications of in utero gene therapy into account, 
ciliary disease in the embryo will ever be targeted for correction as the point by 
which the embryo would have to be genotyped and treated would be very early in 
development. In less severe disease, the kidney might be a treatment target if 
likely immune responses to the vector and/or transgene could ever be 
circumvented. 
 The likelihood of any theoretical cilopathy treatment will depend on the 
success of continued investigations and sustained efforts aimed at understanding 
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the complex protein environment of these structures. More than likely, 
observations made from these studies will also aid our understanding of the 
disease pathogenesis associated with mutations in ciliary genes. As more 
diseases are classified into the category of ciliopathies, this once disregarded 
structure will continue to receive the attention of a diverse group of scientists, 
from developmental and structural biologists to clinicians, alike. There is no 
longer denying the role of the primary cilium in cellular health and function. With 
continued investigation, it will be exciting to observe just how right Karl 
Zimmerman and an undeterred group of scientists were regarding the importance 
of a once vestigial organelle. 
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